Resistant Methylation Motifs

Motif ID	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_adsipsc_promoter_n_RM_14_355_4	2	0.2	2.30E-04	ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_adsipsc_promoter_n_RM_12_268_24	3	0.4	2.73E-04	JAG1, NKX3-1, ATXN1, CARD9	negative regulation of insulin-like growth factor receptor signaling pathway [BP], response to muramyl dipeptide [BP]
CG_adsipsc_promoter_n_RM_14_214_16	9	1.0	2.59E-04	ELOVL1, ACLY	triglyceride biosynthetic process [BP]
CG_adsipsc_promoter_n_RM_12_479_17	2	0.4	2.56E-04	TCF3, MLH3, ADCY9, PUM2, AKT1, MAPK1, SARNP, UBC, FGFR1, FOXP1	female meiosis I [BP], fibroblast growth factor receptor signaling pathway [BP], regulation of translation [BP], immunoglobulin V(D)J recombination [BP]
CG_adsipsc_promoter_n_RM_12_290_14	2	0.4	2.86E-04	PYCARD, BBC3, PTCH1, HEYL, CHST1	positive regulation of antigen processing and presentation of peptide antigen via MHC class II [BP], negative regulation of sequence-specific DNA binding transcription factor activity [BP], intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [BP], intrinsic apoptotic signaling pathway by p53 class mediator [BP], AF-1 domain binding [MF], positive regulation of release of cytochrome c from mitochondria [BP], keratan sulfotransferase activity [MF], regulation of intrinsic apoptotic signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_43_11	3	0.4	3.94E-04	CLASP1	centrosomal corona [CC]
CG_adsipsc_promoter_n_RM_12_281_17	3	0.6	2.43E-04	MGLL, CYP4F2	arachidonic acid metabolic process [BP]
CG_adsipsc_promoter_n_RM_14_378_8	2	0.2	2.64E-04	CAMSAP1, RPS6KA5, BAZ1A	histone H2A-S1 phosphorylation [BP], regulation of cell morphogenesis [BP], ACF complex [CC]
CG_adsipsc_promoter_n_RM_12_477_12	3	0.4	3.16E-04	GATM, BFSP1, STAT5B, CRYGS	structural constituent of eye lens [MF], response to peptide hormone stimulus [BP], cellular response to hormone stimulus [BP], creatine metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_261_11	2	0.2	1.94E-04	PHYH, CS	phytanoyl-CoA dioxygenase activity [MF], citrate (Si)-synthase activity [MF]
CG_adsipsc_promoter_n_RM_12_101_12	3	0.4	2.18E-04	CTBP1, FEV, NOC2L, CALCOCO1, FOXA1	transcription cofactor activity [MF], negative regulation of histone acetylation [BP], neuron fate specification [BP]
CG_adsipsc_promoter_n_RM_12_12_9	4	0.6	2.79E-04	POU4F1	regulation of neurogenesis [BP]
CG_adsipsc_promoter_n_RM_12_127_25	4	0.8	2.10E-04	NCOR2, DLL1	Notch binding [MF]
CG_adsipsc_promoter_n_RM_12_88_9	4	0.6	2.59E-04	BNC1, HOXB3, FOXS1, BATF3, TAF5L, POU2F2, ZSCAN5B, CYP11A1	response to salt stress [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_adsipsc_promoter_n_RM_12_457_13	4	0.8	3.69E-04	CDK5	Schwann cell development [BP], cerebellar cortex formation [BP]
CG_adsipsc_promoter_n_RM_12_144_15	2	0.4	3.19E-04	CDKN2A, PCGF2, MIER2, CD34, ZBTB39, EZH2, HOXA2, ZNF777, CTBP1, POLR2L, EEF1D, WNT11, RAB35	positive regulation of transforming growth factor beta production [BP], segment specification [BP], intercellular bridge [CC], negative regulation of transcription, DNA-dependent [BP], negative regulation of gene expression [BP], DNA binding [MF]
CG_adsipsc_promoter_n_RM_12_160_10	2	0.4	1.74E-04	FLNA, TOP2B, IRS1, EDF1	protein kinase C binding [MF], regulation of lipid metabolic process [BP]
CG_adsipsc_promoter_n_RM_14_153_2	1	0.2	2.92E-04	HIBCH, AKR7A3	3-hydroxyisobutyryl-CoA hydrolase activity [MF], aflatoxin catabolic process [BP]
CG_adsipsc_promoter_n_RM_14_112_3	2	0.2	3.84E-04	STAT5B, LMO2, HIP1, SNAP91	clathrin binding [MF], clathrin coat assembly [BP], negative regulation of erythrocyte differentiation [BP]
CG_adsipsc_promoter_n_RM_14_127_6	3	0.2	2.53E-04	RAB27A, AXIN2, AUH, SH3PXD2B	protein domain specific binding [MF], methylglutaconyl-CoA hydratase activity [MF], cytotoxic T cell degranulation [BP], regulation of chondrocyte development [BP], cell projection [CC]
CG_adsipsc_promoter_n_RM_12_283_18	6	0.8	3.20E-04	CASP3, EXT1, PAXIP1, CDKN2A	positive regulation of isotype switching [BP], cyclin-dependent protein kinase inhibitor activity [MF], cellular polysaccharide biosynthetic process [BP], negative regulation of B cell proliferation [BP], negative regulation of cyclin-dependent protein kinase activity [BP]
CG_adsipsc_promoter_n_RM_14_299_7	2	0.2	6.28E-04	BCOR, IRF7	negative regulation of histone H3-K36 methylation [BP], regulation of MyD88-independent toll-like receptor signaling pathway [BP], immunoglobulin mediated immune response [BP]
CG_adsipsc_promoter_n_RM_18_3_22	4	0.4	4.43E-04	FBXO11, BCL11A, INO80, USP7, TAF11, FOXI3, SETD3, IKZF2, SIX4, NFE2L2, EOMES, ESRP2, ZIC5, NEUROG2, IRX2, ZBTB2, MECP2, ZNF367, TCEA1, BCOR, MEX3D, EVX2, THOC7, MEX3C, NKX6-1, APBA1, HOXA1, SMEK2, ONECUT1	DNA binding [MF], nucleus [CC], positive regulation of transcription, DNA-dependent [BP], nucleic acid binding [MF], transcription factor binding [MF], RNA polymerase II activating transcription factor binding [MF], sequence-specific DNA binding [MF], sequence-specific DNA binding transcription factor activity [MF], positive regulation of transcription from RNA polymerase II promoter [BP], histone H3-K36 methylation [BP], embryo development [BP], negative regulation of histone methylation [BP], transcription from RNA polymerase II promoter [BP], central nervous system neuron differentiation [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_211_9	3	0.6	2.33E-04	SFRP2	negative regulation of peptidyl-tyrosine phosphorylation [BP]
CG_adsipsc_promoter_n_RM_12_422_22	4	0.8	3.34E-04	HAND2, JAK3	cartilage morphogenesis [BP], regulation of T cell apoptotic process [BP]
CG_adsipsc_promoter_n_RM_12_176_7	7	1.0	2.78E-04	HVCN1, SOD2, IRS1, HDAC5, TOP2B	detection of oxygen [BP], protein kinase C binding [MF], response to zinc ion [BP]
CG_adsipsc_promoter_n_RM_12_248_16	3	0.4	2.71E-04	ZBTB46, LONRF2, ZNF585B, THRB, HMGB1, DEAF1, ZFHX3, ZFHX2, ZNF597, ZNF180, ZIC5, ZNF768, ZNF837, ZNF764, ZNF503, TOP3A, WIZ, PDZRN3, ZNF674	DNA topological change [BP], zinc ion binding [MF]
CG_adsipsc_promoter_n_RM_14_107_4	2	0.2	3.22E-04	ADAMTS8, BMP4	BMP signaling pathway involved in renal system segmentation [BP], bud dilation involved in lung branching [BP], specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [BP], negative regulation of glomerulus development [BP], negative regulation of mesenchymal cell proliferation involved in ureter development [BP], negative regulation of metanephric comma-shaped body morphogenesis [BP], negative regulation of cell proliferation involved in heart morphogenesis [BP], negative regulation of metanephric S-shaped body morphogenesis [BP], pulmonary artery endothelial tube morphogenesis [BP], BMP signaling pathway involved in nephric duct formation [BP], negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [BP], intermediate mesodermal cell differentiation [BP], low affinity phosphate transmembrane transporter activity [MF], BMP signaling pathway involved in ureter morphogenesis [BP], ureter epithelial cell differentiation [BP], positive regulation of cardiac muscle fiber development [BP]
CG_adsipsc_promoter_n_RM_14_377_5	4	0.6	1.91E-04	PASK, AP3B2	regulation of respiratory gaseous exchange [BP], clathrin-coated vesicle membrane [CC]
CG_adsipsc_promoter_n_RM_14_99_15	4	0.6	4.61E-04	HMGB2, SMARCC1, DUSP8, DUSP10, SMARCC2	npBAF complex [CC], nBAF complex [CC], MAP kinase tyrosine/serine/threonine phosphatase activity [MF], V(D)J recombination [BP]
CG_adsipsc_promoter_n_RM_12_110_26	5	0.8	3.50E-04	PYCR1, ETV5, MBD2, MBD1	cellular response to oxidative stress [BP], heterochromatin [CC], methyl-CpG binding [MF]
CG_adsipsc_promoter_n_RM_16_2_6	2	0.2	2.72E-04	EZH2	core promoter binding [MF]
CG_adsipsc_promoter_n_RM_14_123_3	1	0.2	2.92E-04	RNASET2	ribonuclease T2 activity [MF]
CG_adsipsc_promoter_n_RM_14_46_7	2	0.4	2.74E-04	SIX1	aorta morphogenesis [BP]
CG_adsipsc_promoter_n_RM_16_41_4	1	0.2	3.22E-04	OCA2, DEAF1	arsenite transport [BP], germ cell development [BP], tyrosine transport [BP], L-tyrosine transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_12_406_6	4	0.6	3.00E-04	FKBP5, DNAJB8, GPR143, HID1	chaperone-mediated protein folding [BP], L-DOPA binding [MF], L-DOPA receptor activity [MF], heat shock protein binding [MF], extrinsic to Golgi membrane [CC]
CG_adsipsc_promoter_n_RM_14_110_3	5	0.4	2.35E-04	SLC19A1, PRICKLE1	methotrexate transport [BP], methotrexate transporter activity [MF], negative regulation of cardiac muscle cell myoblast differentiation [BP]
CG_adsipsc_promoter_n_RM_14_369_10	3	0.4	3.18E-04	FZD4	negative regulation of cell-substrate adhesion [BP]
CG_adsipsc_promoter_n_RM_14_253_9	2	0.4	5.17E-04	NFIB	cerebellar mossy fiber [CC], negative regulation of mesenchymal cell proliferation involved in lung development [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_431_24	4	0.8	2.78E-04	POLG2, MLH3, DMC1, HMGB1	chromosome [CC], single-stranded DNA binding [MF]
CG_adsipsc_promoter_n_RM_14_125_6	2	0.2	2.83E-04	GLRX2, TXN	peptide disulfide oxidoreductase activity [MF], protein disulfide oxidoreductase activity [MF]
CG_adsipsc_promoter_n_RM_12_308_6	4	0.6	1.42E-04	MDC1, GANAB	FHA domain binding [MF], glucosidase II complex [CC], glucan 1,3-alpha-glucosidase activity [MF]
CG_adsipsc_promoter_n_RM_12_167_14	5	0.8	3.71E-04	LHX3, SOD2, CYP11A1, MYO1E, LPCAT1, FOXS1, ATOH7, DLL1, PER1, RUNX1, LPCAT3, TMEM176B, WNT7B, NKX2-5, RSPO2	vasculogenesis [BP], entrainment of circadian clock [BP], trachea cartilage morphogenesis [BP], oxygen homeostasis [BP], organ morphogenesis [BP], detection of oxygen [BP], blood vessel development [BP], hemopoiesis [BP], response to L-ascorbic acid [BP], negative regulation of myeloid cell differentiation [BP], 1-acylglycerophosphocholine O-acyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_16_43_2	1	0.2	6.58E-04	TXNRD2, GNG12, ARRDC3, GNG4	cellular response to glucagon stimulus [BP], response to oxygen radical [BP], heterotrimeric G-protein complex [CC], negative regulation of locomotion involved in locomotory behavior [BP], negative regulation of heat generation [BP]
CG_adsipsc_promoter_n_RM_14_44_6	2	0.2	2.92E-04	SRXN1, LBX1	sulfiredoxin activity [MF], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP]
CG_adsipsc_promoter_n_RM_12_18_11	3	0.6	2.28E-04	YME1L1, SMAD2, OTX2, FRAT2, HDAC4, ZNF768, CTBP1, CORO2A, BCAR1, SIN3A, CREG1	cell proliferation [BP], transcriptional repressor complex [CC], activating transcription factor binding [MF], repressing transcription factor binding [MF], dorsal/ventral pattern formation [BP], negative regulation of histone acetylation [BP], protein deacetylation [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_475_17	6	1.0	1.99E-04	NPPC	negative regulation of DNA metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_29_8	4	0.8	2.35E-04	AXIN1, HRAS, MYH9, NCL, INSRR, CENPV, KPNA3, CACNA1S, TJP1	protein C-terminus binding [MF], actin cytoskeleton reorganization [BP], carbon-sulfur lyase activity [MF], myoblast fusion [BP]
CG_adsipsc_promoter_n_RM_14_171_3	2	0.2	1.69E-04	IDI1, EARS2, ATPAF2	glutamate-tRNA ligase activity [MF], proton-transporting ATP synthase complex assembly [BP], isopentenyl-diphosphate delta-isomerase activity [MF], glutamyl-tRNA aminoacylation [BP], dimethylallyl diphosphate biosynthetic process [BP], glutamate-tRNA(Gln) ligase activity [MF], mitochondrion [CC]
CG_adsipsc_promoter_n_RM_12_274_10	4	0.8	2.68E-04	PENK, HEG1, SMAD2, GRIN2B	behavioral fear response [BP], pericardium development [BP]
CG_adsipsc_promoter_n_RM_14_131_8	3	0.2	2.67E-04	SDC1, AHI1, BCOR, TOP2A, HMGB2	specification of axis polarity [BP], DNA topological change [BP], odontogenesis [BP], DNA ligation [BP]
CG_adsipsc_promoter_n_RM_14_40_4	3	0.4	3.41E-04	SGK1, UCKL1, CKB, HSPA12A, CDK4, OPRK1, PANK4	ATP binding [MF], dynorphin receptor activity [MF]
CG_adsipsc_promoter_n_RM_12_192_8	2	0.4	3.99E-04	KCNV1, COG4, TNNI3	ion channel inhibitor activity [MF], Golgi vesicle prefusion complex stabilization [BP], regulation of systemic arterial blood pressure by ischemic conditions [BP]
CG_adsipsc_promoter_n_RM_12_134_9	6	1.0	2.93E-04	LPHN1, CELSR1, ECEL1	neuropeptide signaling pathway [BP]
CG_adsipsc_promoter_n_RM_14_330_9	2	0.2	2.57E-04	NR3C1, SMURF2, ZNF3, MLXIPL, TBX20, E2F2, RBBP7, PSMD10, ZFHX3, SMARCC1, BCOR, CRMP1, PBX4, ZSCAN23, LGR4	nucleobase-containing compound metabolic process [BP], negative regulation of transcription from RNA polymerase II promoter [BP], RNA metabolic process [BP], transcription factor binding [MF], regulation of transcription, DNA-dependent [BP], XY body [CC], transcription, DNA-dependent [BP], negative regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], transcription regulatory region DNA binding [MF], gene expression [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_228_13	4	0.8	3.03E-04	PTK2, GSK3A, TLR9, SREBF1, AKT2	JNK cascade [BP], negative regulation of organ growth [BP], insulin receptor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_172_8	5	0.8	2.81E-04	STAT1, CDX2, SYCE1, SYCE2, SLC4A7, MTSS1, CITED1, WNT7B, FGFR1, PDGFRB	labyrinthine layer development [BP], retina vasculature development in camera-type eye [BP], auditory receptor cell development [BP], renal tubule development [BP], nephron tubule epithelial cell differentiation [BP], metanephros morphogenesis [BP], negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [BP], glomerulus morphogenesis [BP], central element [CC], metanephros development [BP], lung-associated mesenchyme development [BP]
CG_adsipsc_promoter_n_RM_14_56_11	2	0.2	3.47E-04	GSK3A, NKX3-1, RUNX1	positive regulation of androgen secretion [BP], positive regulation of progesterone secretion [BP], negative regulation of UDP-glucose catabolic process [BP], MADS box domain binding [MF], positive regulation of response to DNA damage stimulus [BP]
CG_adsipsc_promoter_n_RM_14_297_7	1	0.2	1.50E-04	TRIT1, UBC, A4GALT	hypothalamus gonadotrophin-releasing hormone neuron development [BP], lactosylceramide 4-alpha-galactosyltransferase activity [MF], tRNA dimethylallyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_340_3	1	0.2	3.42E-04	OPLAH, HSPG2, AXIN2, GDNF, NOP14	Noc4p-Nop14p complex [CC], 5-oxoprolinase (ATP-hydrolyzing) activity [MF], mRNA stabilization [BP], cartilage development involved in endochondral bone morphogenesis [BP], regulation of chondrocyte development [BP]
CG_adsipsc_promoter_n_RM_12_325_10	4	0.6	3.13E-04	ERCC1	embryonic organ development [BP]
CG_adsipsc_promoter_n_RM_12_174_5	1	0.2	2.06E-04	NRL, RPS6KA5	positive regulation of rhodopsin gene expression [BP], histone H2A-S1 phosphorylation [BP], histone H3-S10 phosphorylation [BP], regulation of rhodopsin gene expression [BP], histone H3-S28 phosphorylation [BP]
CG_adsipsc_promoter_n_RM_12_243_10	6	0.8	2.59E-04	EGR2, TRAPPC3, PCSK6, RAB6A, NOTCH2, NGF	rhombomere 3 formation [BP], rhombomere 5 formation [BP], morphogenesis of an epithelial sheet [BP], positive regulation of nerve growth factor receptor signaling pathway [BP], nerve growth factor processing [BP], peptide hormone processing [BP], nerve growth factor receptor binding [MF], Golgi apparatus [CC]
CG_adsipsc_promoter_n_RM_14_334_4	2	0.2	3.08E-04	ABCF2, ABCA2	ATP-binding cassette (ABC) transporter complex [CC]
CG_adsipsc_promoter_n_RM_12_436_13	3	0.6	2.81E-04	SULF2, GFRA2, NID1	glial cell-derived neurotrophic factor receptor signaling pathway [BP], glomerular basement membrane development [BP]
CG_adsipsc_promoter_n_RM_14_174_6	3	0.2	2.76E-04	PIAS2, GPLD1, RPS6KA5, DGKQ, CBX4	GPI anchor release [BP], cellular response to triglyceride [BP], transepithelial transport [BP], protein sumoylation [BP], nuclear speck [CC], histone H2A-S1 phosphorylation [BP], glycosylphosphatidylinositol phospholipase D activity [MF]
CG_adsipsc_promoter_n_RM_14_88_12	10	0.8	4.83E-04	POU3F1, TCFL5, ASCL2, TSPAN12, RXRG, CSRNP1, SOX10, RUNX1, FOXL2, PLXND1, TRIP12, HOXA4, EZH2, NCKAP1, ZC3H8	regulation of angiogenesis [BP], peripheral nervous system development [BP], sequence-specific DNA binding transcription factor activity [MF], central nervous system development [BP], sequence-specific DNA binding [MF], regulation of gliogenesis [BP], embryo development [BP], multicellular organismal development [BP]
CG_adsipsc_promoter_n_RM_14_293_6	2	0.2	1.90E-04	UGDH	UDP-glucose 6-dehydrogenase activity [MF]
CG_adsipsc_promoter_n_RM_14_67_5	1	0.2	3.85E-04	PNPLA8, LPCAT1, GIPC1	phosphatidylcholine acyl-chain remodeling [BP], negative regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_adsipsc_promoter_n_RM_12_466_10	5	0.8	3.48E-04	HOXA2, FOXP1	motor neuron axon guidance [BP]
CG_adsipsc_promoter_n_RM_12_453_15	6	1.0	4.13E-04	SH3PXD2A, AKT1	response to food [BP], phosphatidylinositol binding [MF]
CG_adsipsc_promoter_n_RM_12_221_13	6	0.8	3.68E-04	SFRP1, FEZF1, ADRA2B, FOXA1	negative regulation of epithelial to mesenchymal transition [BP], positive regulation of neuron differentiation [BP]
CG_adsipsc_promoter_n_RM_14_311_3	1	0.2	1.71E-04	PKD1, PNKP, TWF1	regulation of actin phosphorylation [BP], nucleotide phosphorylation [BP], metanephric distal tubule morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_291_5	2	0.2	2.87E-04	JUP	protein-DNA complex [CC], internal side of plasma membrane [CC]
CG_adsipsc_promoter_n_RM_18_12_3	2	0.2	2.54E-04	ROCK2, DLC1	regulation of stress fiber assembly [BP], focal adhesion assembly [BP], positive regulation of centrosome duplication [BP]
CG_adsipsc_promoter_n_RM_12_230_9	5	0.8	2.49E-04	CFL1, PIEZO2, CACNB1, KCNQ2, SOHLH1, BAD, GRIN2A, COL4A1, IRF7	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity [MF], response to amino acid stimulus [BP], calcium channel activity [MF], cation channel activity [MF], axon guidance [BP], response to ethanol [BP], cell differentiation [BP]
CG_adsipsc_promoter_n_RM_12_59_12	3	0.6	1.54E-04	PTK2, WNT7B, LEF1	negative regulation of cell-cell adhesion [BP], embryonic placenta morphogenesis [BP], chorio-allantoic fusion [BP], anatomical structure regression [BP]
CG_adsipsc_promoter_n_RM_14_315_5	2	0.2	5.02E-04	FOXL2, PGM3, PRICKLE1	female somatic sex determination [BP], phosphoacetylglucosamine mutase activity [MF], menstruation [BP], negative regulation of cardiac muscle cell myoblast differentiation [BP]
CG_adsipsc_promoter_n_RM_12_131_22	5	0.8	2.72E-04	ZC3H8, GBX1, ZNF132, NR2F6, HOXA13, SIX1, KDM5A, HOXA1, FLNA, RELA, YWHAG, PRC1, MAD2L2	sequence-specific DNA binding [MF], cochlea morphogenesis [BP], generation of neurons [BP], sequence-specific DNA binding transcription factor activity [MF], artery morphogenesis [BP], negative regulation of protein catabolic process [BP], artery development [BP], regulation of neuron differentiation [BP], facial nerve morphogenesis [BP], protein kinase binding [MF]
CG_adsipsc_promoter_n_RM_12_124_14	5	0.8	2.77E-04	LOX, GNB1, C1QL1	cardiac muscle cell apoptotic process [BP], collagen [CC]
CG_adsipsc_promoter_n_RM_14_20_3	1	0.2	3.65E-04	MEX3D	mRNA localization resulting in posttranscriptional regulation of gene expression [BP]
CG_adsipsc_promoter_n_RM_14_351_5	3	0.4	3.24E-04	PLXND1, PRKX, PLCD1, FZD8	angiogenesis [BP], vasculature development [BP], endothelial cell migration [BP]
CG_adsipsc_promoter_n_RM_14_103_8	5	0.6	1.09E-04	ARHGAP21	maintenance of Golgi location [BP]
CG_adsipsc_promoter_n_RM_14_176_6	2	0.2	2.16E-04	DMGDH, HMGB1	negative regulation of apoptotic cell clearance [BP], dimethylglycine dehydrogenase activity [MF]
CG_adsipsc_promoter_n_RM_16_23_6	5	0.4	3.26E-04	TMEM229A, MPC1, PGAM2	host cell nucleus [CC], 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF], mitochondrial pyruvate transport [BP]
CG_adsipsc_promoter_n_RM_14_239_6	3	0.4	1.81E-04	GALNS, SEC31A, UROS, MCFD2	N-acetylgalactosamine-6-sulfatase activity [MF], ER to Golgi transport vesicle membrane [CC], cellular response to amine stimulus [BP], uroporphyrinogen-III synthase activity [MF], ER to Golgi transport vesicle [CC]
CG_adsipsc_promoter_n_RM_14_116_6	9	0.8	2.41E-04	WNT11, USP4	protein localization to cell surface [BP]
CG_adsipsc_promoter_n_RM_12_74_15	5	0.8	3.36E-04	NKX3-1, CDK6, GNE, NR3C1	MADS box domain binding [MF], N-acylmannosamine kinase activity [MF], cell dedifferentiation [BP], positive regulation of androgen secretion [BP], glucocorticoid receptor activity [MF], UDP-N-acetylglucosamine 2-epimerase activity [MF]
CG_adsipsc_promoter_n_RM_14_9_7	2	0.2	3.51E-04	GATA2, MEX3D	negative regulation of fat cell proliferation [BP], mRNA localization resulting in posttranscriptional regulation of gene expression [BP]
CG_adsipsc_promoter_n_RM_14_357_4	2	0.2	2.51E-04	SLC5A6, PLXNA2	cerebellar granule cell precursor tangential migration [BP], biotin transport [BP], pantothenate transmembrane transport [BP]
CG_adsipsc_promoter_n_RM_12_236_7	2	0.2	2.34E-04	UBE2N, UBC	nucleotide-binding oligomerization domain containing signaling pathway [BP], positive regulation of ubiquitin-protein ligase activity [BP]
CG_adsipsc_promoter_n_RM_14_319_2	2	0.2	5.85E-04	FASN, SLBP	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], oleoyl-[acyl-carrier-protein] hydrolase activity [MF], myristoyl-[acyl-carrier-protein] hydrolase activity [MF], [acyl-carrier-protein] S-malonyltransferase activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], 3-oxoacyl-[acyl-carrier-protein] synthase activity [MF], palmitoyl-[acyl-carrier-protein] hydrolase activity [MF], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], histone pre-mRNA stem-loop binding [MF]
CG_adsipsc_promoter_n_RM_14_379_9	2	0.2	4.01E-04	TSHZ3, BRD3, MNT, PRMT5, TAL1	chromatin binding [MF]
CG_adsipsc_promoter_n_RM_12_407_11	4	0.6	3.78E-04	EGR2	protein export from nucleus [BP]
CG_adsipsc_promoter_n_RM_12_329_22	3	0.4	2.78E-04	GBX2, BAD, IRS1, NRARP, CRMP1	phosphatidylinositol-mediated signaling [BP], cerebellum development [BP], hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [MF], regulation of cell-cell adhesion [BP], phosphatidylinositol 3-kinase cascade [BP]
CG_adsipsc_promoter_n_RM_14_75_11	3	0.4	3.97E-04	BAZ1A, DLG4, MAD1L1	ACF complex [CC], mitotic telophase [BP], P2Y1 nucleotide receptor binding [MF]
CG_adsipsc_promoter_n_RM_14_317_4	2	0.2	4.02E-04	PATL1, ACADL	regulation of cholesterol metabolic process [BP], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_n_RM_16_21_8	2	0.2	2.77E-04	CITED1, NOTCH1, MKL1, PABPC1	negative regulation of osteoblast differentiation [BP], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], regulation of extracellular matrix assembly [BP], negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP], response to interleukin-11 [BP], venous endothelial cell differentiation [BP], smooth muscle cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_5_6	2	0.2	1.91E-04	POU4F1, CRAT	carnitine O-acetyltransferase activity [MF], proprioception involved in equilibrioception [BP]
CG_adsipsc_promoter_n_RM_12_71_17	3	0.4	1.82E-04	FEZF1, TBX20, MLH3, FOXA1, RBMS1, NEUROG1, SSBP2, SEMA3C	cardiac right ventricle morphogenesis [BP], single-stranded DNA binding [MF], positive regulation of neuron differentiation [BP]
CG_adsipsc_promoter_n_RM_12_355_11	3	0.6	1.98E-04	SRPX, MAP2K2, MEFV, DUSP7, DUSP6, SIN3A, AP2S1	toll-like receptor 4 signaling pathway [BP], MAP kinase tyrosine/serine/threonine phosphatase activity [MF], toll-like receptor 1 signaling pathway [BP], inactivation of MAPK activity [BP], nerve growth factor receptor signaling pathway [BP], toll-like receptor 3 signaling pathway [BP], toll-like receptor 2 signaling pathway [BP], innate immune response [BP], MyD88-dependent toll-like receptor signaling pathway [BP], Toll signaling pathway [BP], toll-like receptor signaling pathway [BP], activation of innate immune response [BP], cellular response to stress [BP], MyD88-independent toll-like receptor signaling pathway [BP], TRIF-dependent toll-like receptor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_67_17	2	0.4	2.59E-04	ERO1LB, MGAT1	oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [MF], acetylglucosaminyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_79_7	5	0.6	4.15E-04	DUOX2	inner ear development [BP]
CG_adsipsc_promoter_n_RM_12_54_12	4	0.6	3.83E-04	FASN, NRP1, ELOVL1, TBX20	long-chain fatty-acyl-CoA biosynthetic process [BP], patterning of blood vessels [BP], acetyl-CoA metabolic process [BP], fatty acid biosynthetic process [BP], fatty acid synthase activity [MF]
CG_adsipsc_promoter_n_RM_12_497_16	3	0.6	2.55E-04	CCDC88C, CTSH	protein self-association [MF], protein destabilization [BP]
CG_adsipsc_promoter_n_RM_16_22_6	2	0.4	4.64E-04	TAL1, ZC3H8, MEIS2, ZFP36L2, TBX18, FGFR2, PRICKLE1	Lsd1/2 complex [CC], negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], negative regulation of cardiac muscle cell myoblast differentiation [BP], fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP], negative regulation of transcription from RNA polymerase II promoter [BP], positive regulation of mesenchymal cell proliferation [BP], regulation of transcription, DNA-dependent [BP], morphogenesis of embryonic epithelium [BP], fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP], hemangioblast cell differentiation [BP], sequence-specific DNA binding [MF], positive regulation of cell division [BP], negative regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP], hemopoiesis [BP], coronal suture morphogenesis [BP], smooth muscle cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_86_8	2	0.2	3.17E-04	TONSL, PURB, EMC8, EMC1, RHEB, GOLPH3	DNA replication factor A complex [CC], positive regulation of TOR signaling cascade [BP], ER membrane protein complex [CC]
CG_adsipsc_promoter_n_RM_14_257_11	5	0.8	2.94E-04	DDB1, FBXW4, TLE1	Wnt receptor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_321_18	3	0.4	3.73E-04	CHD1, CCNL2, CHD5, SIN3A, NFIB, SRSF4, AHNAK, PDS5A, EVC2, SAV1, IRF2BP2, LSG1, PPIL4, CDK5, ANKRD23, SETD2, MTMR2, FLT1, SMURF1	receptor catabolic process [BP], peptidyl-lysine trimethylation [BP], lung epithelial cell differentiation [BP], nuclear export [BP], RNA polymerase II transcription corepressor activity [MF], nucleus [CC]
CG_adsipsc_promoter_n_RM_14_232_8	1	0.2	3.61E-04	NEUROG1, POLE, H2AFY, CDCA5, HESX1	mitotic cell cycle [BP], chromatin binding [MF]
CG_adsipsc_promoter_n_RM_12_270_22	5	1.0	2.88E-04	GNB1, TXN2, SHARPIN, ANKS1B, GRM5, SRCIN1, P4HB	dendrite [CC], glycerol ether metabolic process [BP], postsynaptic density [CC]
CG_adsipsc_promoter_n_RM_12_76_19	7	1.0	3.41E-04	APBB1, POU4F1	axonogenesis [BP], synapse assembly [BP]
CG_adsipsc_promoter_n_RM_16_5_22	9	1.0	4.07E-04	PTK2, PAX3, NUAK1, ZFHX3, TAF11, RBMS1, WASL, SOX3, CPSF7, MAFA, SETD3, PERP, COMMD6, CDK2AP1, ESRP2, ZIC5, NECAB3, TOP2A, DDIT3, ZZZ3, DNASE1L1, EVX2, VCP, ARFGEF1, BCOR, TP53BP2, MEX3D, THOC7, MEX3C, LIN54, TBL1XR1, KLLN, RFX2, TOX3, HOXA1, PIP4K2B, CUL3, LCORL, GTF2A1, LMF1	protein glycosylation in Golgi [BP], nucleus [CC], histone H3-K36 methylation [BP], DNA binding [MF], embryonic cleavage [BP], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_n_RM_14_236_7	2	0.2	3.53E-04	NIN, ATE1, ZC3H3	protein arginylation [BP], arginyltransferase activity [MF], regulation of mRNA export from nucleus [BP], centrosome-templated microtubule nucleation [BP]
CG_adsipsc_promoter_n_RM_14_29_4	2	0.2	3.12E-04	NFIB	cerebellar mossy fiber [CC], principal sensory nucleus of trigeminal nerve development [BP], Type I pneumocyte differentiation [BP], negative regulation of mesenchymal cell proliferation involved in lung development [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_272_6	2	0.2	3.77E-04	DUSP1, CDK5, DUSP16	nucleocytoplasmic transport [BP], neuron apoptotic process [BP], MAP kinase tyrosine/serine/threonine phosphatase activity [MF]
CG_adsipsc_promoter_n_RM_12_352_12	5	0.8	2.68E-04	KEAP1	regulation of epidermal cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_7_5	2	0.2	3.12E-04	MED22, TGFB3, MED14, DUSP18, BCL9L, DUSP10, PPP2CB	protein dephosphorylation [BP], MAP kinase tyrosine/serine/threonine phosphatase activity [MF], MAP kinase phosphatase activity [MF], mediator complex [CC], positive regulation of epithelial to mesenchymal transition [BP], stem cell maintenance [BP]
CG_adsipsc_promoter_n_RM_12_81_13	5	0.8	3.43E-04	MTHFSD, AK3	ITP metabolic process [BP], 5-formyltetrahydrofolate cyclo-ligase activity [MF], nucleoside triphosphate adenylate kinase activity [MF]
CG_adsipsc_promoter_n_RM_14_235_5	2	0.2	2.71E-04	DLG4, UBXN1, PLD6	P2Y1 nucleotide receptor binding [MF], neuron projection terminus [CC], cardiolipin hydrolase activity [MF], K6-linked polyubiquitin binding [MF]
CG_adsipsc_promoter_n_RM_12_429_16	5	1.0	2.14E-04	GALNS	N-acetylgalactosamine-6-sulfatase activity [MF]
CG_adsipsc_promoter_n_RM_14_230_7	2	0.2	1.84E-04	HRAS, GPC4, CDK11B, WNT4, TFAP2A	cell proliferation [BP], positive regulation of bone mineralization [BP]
CG_adsipsc_promoter_n_RM_12_99_13	4	0.8	2.01E-04	HOXB3	rhombomere development [BP]
CG_adsipsc_promoter_n_RM_12_264_13	5	0.8	2.12E-04	CALY, AP2S1, CCDC88C, CSNK1D, JUP, SHH, ITGA8	Wnt receptor signaling pathway [BP], ectoderm development [BP], smooth muscle tissue development [BP], clathrin coat assembly [BP], positive regulation of Wnt receptor signaling pathway [BP], canonical Wnt receptor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_84_9	4	0.8	2.84E-04	DUSP16, DUSP8, NKX2-5, ADRA1A	MAP kinase tyrosine/serine/threonine phosphatase activity [MF], adult heart development [BP]
CG_adsipsc_promoter_n_RM_14_274_6	2	0.2	2.30E-04	CHST10, PCYT2, HS6ST1, NACC2	HNK-1 sulfotransferase activity [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], sulfotransferase activity [MF], ethanolamine-phosphate cytidylyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_358_4	2	0.2	3.16E-04	APBB1, B3GAT3, COPZ2, HOXA2, CDCA5, GAS1, CHMP1A, FOXP1	negative regulation of mitotic cell cycle [BP], middle ear morphogenesis [BP], cis-Golgi network [CC], negative regulation of S phase of mitotic cell cycle [BP], mitotic chromosome condensation [BP], motor neuron axon guidance [BP]
CG_adsipsc_promoter_n_RM_14_387_5	3	0.4	3.87E-04	BAD, CRH	positive regulation of insulin secretion involved in cellular response to glucose stimulus [BP], hypothalamus development [BP]
CG_adsipsc_promoter_n_RM_12_259_12	3	0.6	3.05E-04	RAD21, WAPAL	protein localization to chromatin [BP], cohesin complex [CC]
CG_adsipsc_promoter_n_RM_14_295_10	1	0.2	3.00E-04	PGM3, HOXB2	glucosamine metabolic process [BP], neural nucleus development [BP]
CG_adsipsc_promoter_n_RM_12_395_30	5	0.8	3.75E-04	EHD1, NFKBIA, CDKL1, STAT5B, BCOR, TBX5, PTCH1, RAB14, JAG1	endocytic recycling [BP], response to muramyl dipeptide [BP], heart development [BP], positive regulation of cholesterol efflux [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_150_6	3	0.6	2.36E-04	SEPT10, GNAQ, KCNMA1, SEPT8	regulation of action potential in neuron [BP], regulation of membrane potential [BP], septin complex [CC], regulation of action potential [BP]
CG_adsipsc_promoter_n_RM_14_198_4	1	0.2	2.71E-04	PGM3, PGM2L1	phosphoacetylglucosamine mutase activity [MF], glucose-1,6-bisphosphate synthase activity [MF]
CG_adsipsc_promoter_n_RM_14_381_5	1	0.2	2.65E-04	OXCT1, DNASE2	3-oxoacid CoA-transferase activity [MF], deoxyribonuclease II activity [MF]
CG_adsipsc_promoter_n_RM_12_235_11	3	0.4	2.51E-04	SLC47A2, COMP	antiporter activity [MF], limb development [BP]
CG_adsipsc_promoter_n_RM_14_136_10	2	0.2	2.29E-04	REV1	deoxycytidyl transferase activity [MF], error-prone translesion synthesis [BP]
CG_adsipsc_promoter_n_RM_14_234_8	2	0.2	3.37E-04	KIF7, VDAC1, PTCH1, DLG4, GRIN2B	behavioral fear response [BP], learning [BP], negative regulation of smoothened signaling pathway [BP], learning or memory [BP]
CG_adsipsc_promoter_n_RM_14_213_21	9	1.0	3.99E-04	RAB9B, LDHB, ME3, MPC1, KIF16B	pyruvate metabolic process [BP], Golgi to endosome transport [BP]
CG_adsipsc_promoter_n_RM_12_177_13	3	0.4	2.89E-04	MSI1, NCAPD3, RHOBTB1, GNAT2, RHOF, YBX2, RAB23	polysome [CC], nuclear condensin complex [CC], GTP binding [MF]
CG_adsipsc_promoter_n_RM_14_150_3	3	0.4	3.28E-04	TJP1, SLC30A1, HOXA1, GSK3B, CH25H	optokinetic behavior [BP], negative regulation of zinc ion transmembrane import [BP], cell-cell signaling involved in cell-cell junction organization [BP], canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process [BP], abducens nerve formation [BP], cholesterol 25-hydroxylase activity [MF]
CG_adsipsc_promoter_n_RM_12_83_12	2	0.4	2.61E-04	CBX4, CBX8, PCDH8	PRC1 complex [CC], morphogenesis of embryonic epithelium [BP]
CG_adsipsc_promoter_n_RM_12_464_28	7	1.0	3.38E-04	INSR, SULT1A2, HSP90AA1	amine biosynthetic process [BP], positive regulation of nitric oxide biosynthetic process [BP]
CG_adsipsc_promoter_n_RM_12_427_12	3	0.6	1.89E-04	HOXA1, SIX1	facial nerve morphogenesis [BP], embryonic cranial skeleton morphogenesis [BP], cochlea development [BP], cochlea morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_409_5	4	0.6	2.34E-04	FOXA2	negative regulation of detection of glucose [BP], negative regulation of transcription from RNA polymerase II promoter by glucose [BP], regulation of transcription from RNA polymerase II promoter involved in detection of glucose [BP]
CG_adsipsc_promoter_n_RM_14_220_8	4	0.8	3.01E-04	PTCH1, GLI3	dorsal/ventral neural tube patterning [BP], negative regulation of smoothened signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_499_13	5	0.8	3.47E-04	INSR, POU3F1, CCSAP, TBX20	regulation of embryonic development [BP], RNA polymerase II transcription coactivator activity [MF]
CG_adsipsc_promoter_n_RM_14_385_8	1	0.2	2.75E-04	SFRP4	negative regulation of sodium-dependent phosphate transport [BP]
CG_adsipsc_promoter_n_RM_12_350_4	3	0.4	2.30E-04	ACD, DARS	positive regulation of single-stranded telomeric DNA binding [BP], aspartyl-tRNA aminoacylation [BP]
CG_adsipsc_promoter_n_RM_12_142_15	2	0.4	3.47E-04	BNIP3, IMPAD1, CAMK2B, DTNBP1, SS18	neuron projection development [BP], sarcoplasm [CC], inhibitory G-protein coupled receptor phosphorylation [BP], neuron projection morphogenesis [BP], 3'-nucleotidase activity [MF], cell morphogenesis [BP], cellular response to cobalt ion [BP]
CG_adsipsc_promoter_n_RM_12_9_6	3	0.4	3.56E-04	AIPL1, NUP98, NRP1	farnesylated protein binding [MF], positive regulation of cytokine activity [BP], trigeminal nerve morphogenesis [BP], protein import into nucleus, docking [BP]
CG_adsipsc_promoter_n_RM_14_374_4	6	0.8	3.70E-04	DVL1, WNT7A, UBQLN1, PSMB1, VCP	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP], non-canonical Wnt receptor signaling pathway [BP], proteasome complex [CC], frizzled binding [MF]
CG_adsipsc_promoter_n_RM_14_170_10	7	1.0	3.48E-04	GAS1, TWIST1, MLXIPL	outer ear morphogenesis [BP], anatomical structure morphogenesis [BP], cranial suture morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_262_12	5	1.0	3.43E-04	PAX6, BCOR, NKX2-2, HES2, HES4, PRDM14	transcription factor binding [MF], cell fate specification [BP], neuron fate specification [BP], oligodendrocyte cell fate specification [BP], endocrine pancreas development [BP], spinal cord motor neuron differentiation [BP], type B pancreatic cell development [BP]
CG_adsipsc_promoter_n_RM_12_63_6	2	0.4	7.03E-05	YBX2, NAMPT	translational attenuation [BP], nicotinamide phosphoribosyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_197_4	1	0.2	3.78E-04	BNC1, TBX20, POLR2L	regulation of transcription from RNA polymerase I promoter [BP], embryonic heart tube elongation [BP]
CG_adsipsc_promoter_n_RM_12_96_14	3	0.6	3.47E-04	SMAD2, WNT11, SMAD9, ASPH	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [MF], palate development [BP]
CG_adsipsc_promoter_n_RM_16_28_10	6	0.8	5.09E-04	FGFR2, POU3F1, TOP2B, SOX10	digestive tract morphogenesis [BP], mesenchymal cell proliferation involved in lung development [BP], digestive tract development [BP], branching morphogenesis of a nerve [BP], forebrain development [BP]
CG_adsipsc_promoter_n_RM_12_102_14	3	0.6	3.15E-04	HDAC5, KLF4	negative regulation of cell migration involved in sprouting angiogenesis [BP]
CG_adsipsc_promoter_n_RM_16_40_3	2	0.2	5.29E-04	NADK	NAD+ kinase activity [MF]
CG_adsipsc_promoter_n_RM_14_193_4	1	0.2	2.63E-04	UBE2N, TOP2A, EEA1	viral integration complex [CC], positive regulation of retroviral genome replication [BP], synaptic vesicle to endosome fusion [BP], serine-pyruvate aminotransferase complex [CC], DNA topoisomerase complex (ATP-hydrolyzing) [CC], ubiquitin binding [MF]
CG_adsipsc_promoter_n_RM_12_458_13	2	0.4	4.01E-04	NKX3-1	positive regulation of androgen secretion [BP], androgen receptor activity [MF], MADS box domain binding [MF], negative regulation of estrogen receptor binding [BP]
CG_adsipsc_promoter_n_RM_14_370_5	4	0.4	1.89E-04	TBX18	sinoatrial node development [BP], smooth muscle cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_49_8	3	0.2	8.84E-05	CYBA, WNT3	positive regulation of cell growth [BP], smooth muscle hypertrophy [BP], Spemann organizer formation at the anterior end of the primitive streak [BP], negative regulation of glomerular filtration by angiotensin [BP]
CG_adsipsc_promoter_n_RM_12_367_11	3	0.6	3.54E-04	SFRP4	negative regulation of sodium-dependent phosphate transport [BP]
CG_adsipsc_promoter_n_RM_12_263_12	3	0.4	3.75E-04	PPP4R1	protein phosphatase type 4 regulator activity [MF]
CG_adsipsc_promoter_n_RM_16_12_5	5	0.2	1.39E-04	STAT5B, TXN	response to interleukin-2 [BP], antibiotic metabolic process [BP], development of secondary male sexual characteristics [BP], response to thyroxine stimulus [BP]
CG_adsipsc_promoter_n_RM_14_195_7	2	0.2	3.66E-04	HOXA13, UBE2D3, SIX1, DVL1, LEF1, YWHAG, HEG1	endothelial cell morphogenesis [BP], cochlea morphogenesis [BP], BMP signaling pathway [BP], regulation of signal transduction [BP], receptor clustering [BP], muscle fiber development [BP]
CG_adsipsc_promoter_n_RM_12_344_26	6	1.0	3.61E-04	EEA1, RAPGEF5, RBP4, TUBGCP3, TUBGCP6, TLR9	maintenance of gastrointestinal epithelium [BP], microtubule nucleation [BP], GTP-dependent protein binding [MF]
CG_adsipsc_promoter_n_RM_14_82_2	1	0.2	6.46E-04	AMBP, COL16A1, BAD	response to amino acid stimulus [BP], calcium oxalate binding [MF], collagen type XVI [CC], cellular response to chromate [BP]
CG_adsipsc_promoter_n_RM_12_296_12	2	0.4	1.11E-04	MAFB	rhombomere 6 development [BP]
CG_adsipsc_promoter_n_RM_12_69_9	3	0.4	2.98E-04	POLG, CDK2AP1, BAZ1A	DNA-dependent DNA replication [BP]
CG_adsipsc_promoter_n_RM_12_170_12	4	0.6	2.26E-04	FLT4, HRAS	positive regulation of protein phosphorylation [BP]
CG_adsipsc_promoter_n_RM_12_217_16	4	0.8	2.77E-04	STAT5B	cellular response to hormone stimulus [BP]
CG_adsipsc_promoter_n_RM_12_129_11	2	0.2	3.49E-04	FZD8, PLXNA2, DRD1, SHROOM1, ATP1A3, WNT11, SLC43A1, VAMP2	visual learning [BP], cell morphogenesis [BP], neuron differentiation [BP], integral to plasma membrane [CC]
CG_adsipsc_promoter_n_RM_12_444_11	3	0.4	2.65E-04	PNPLA7, ACP2, AP1G1	lysosomal membrane [CC]
CG_adsipsc_promoter_n_RM_14_328_8	1	0.2	3.72E-04	RANGAP1, CHDH	choline dehydrogenase activity [MF], positive regulation of Ran GTPase activity [BP], Ran GTPase activator activity [MF]
CG_adsipsc_promoter_n_RM_12_140_11	3	0.4	3.84E-04	EPB41L3, SNUPN, EIF4G3	RNA cap binding [MF], myelin maintenance [BP]
CG_adsipsc_promoter_n_RM_12_323_20	8	1.0	3.86E-04	STAT5B	T cell homeostasis [BP], positive regulation of mitotic cell cycle [BP]
CG_adsipsc_promoter_n_RM_12_79_13	3	0.6	3.30E-04	PTCH1, TXN, KCNG1	peptide disulfide oxidoreductase activity [MF], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_n_RM_14_331_2	5	0.6	4.51E-04	UPF3B, THOC7, GLI3, NACC2	mRNA export from nucleus [BP], anterior semicircular canal development [BP], transcriptional repressor complex [CC], lambdoid suture morphogenesis [BP], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], lateral semicircular canal development [BP], sagittal suture morphogenesis [BP], histone deacetylase binding [MF], lateral ganglionic eminence cell proliferation [BP]
CG_adsipsc_promoter_n_RM_16_6_6	5	0.2	3.76E-04	CACNG2, SMAD7, DEK, PROM1, PHLPP2	regulation of double-strand break repair [BP], membrane depolarization [BP], negative regulation of protein ubiquitination [BP], photoreceptor outer segment membrane [CC]
CG_adsipsc_promoter_n_RM_14_66_4	3	0.4	1.53E-04	SEPT12	sperm annulus [CC]
CG_adsipsc_promoter_n_RM_12_420_19	2	0.2	3.98E-04	ANKLE2, SYMPK	positive regulation of protein dephosphorylation [BP]
CG_adsipsc_promoter_n_RM_12_94_14	4	0.8	2.49E-04	SMAD2, NTF4, NOTCH1, HAND2, MGEA5	cardiac right ventricle formation [BP], positive regulation of protein complex disassembly [BP], mechanoreceptor differentiation [BP], activating transcription factor binding [MF], cardiac chamber formation [BP], coronary artery morphogenesis [BP], foregut morphogenesis [BP], pericardium development [BP], regulation of secondary heart field cardioblast proliferation [BP]
CG_adsipsc_promoter_n_RM_14_43_8	3	0.4	3.01E-04	ERRFI1, KCNJ10, COL2A1, NFKBIA, CDK5, CDK6, ADA, JAG2, FGFR2, HEY1, LIPA	oligodendrocyte differentiation [BP], lung alveolus development [BP], gliogenesis [BP], central nervous system myelination [BP], Notch signaling pathway [BP], synaptic vesicle transport [BP], limb bud formation [BP], lung development [BP], cyclin-dependent protein kinase holoenzyme complex [CC], lung epithelium development [BP], negative regulation of Notch signaling pathway [BP], T cell differentiation in thymus [BP], regulation of cell-cell adhesion mediated by integrin [BP]
CG_adsipsc_promoter_n_RM_12_285_19	8	0.8	3.13E-04	DMD, LONRF2, STAT5B, USP31, USP24, CLPX	nucleus localization [BP], ATP-dependent peptidase activity [MF], peptidase activator activity [MF], taurine metabolic process [BP], cysteine-type peptidase activity [MF]
CG_adsipsc_promoter_n_RM_14_383_8	2	0.2	3.36E-04	DOK4, FRS3	insulin receptor binding [MF]
CG_adsipsc_promoter_n_RM_12_70_12	3	0.6	2.67E-04	MLH3, LHX6, UBC, PSAP	epithelial cell differentiation involved in prostate gland development [BP], forebrain neuron development [BP], female meiosis I [BP]
CG_adsipsc_promoter_n_RM_12_244_11	3	0.6	3.44E-04	NKX3-1, ZFR, NFS1, MOCS1, CAMTA2, ACTL6B, TOP2B, SMARCC1	molybdopterin cofactor biosynthetic process [BP], WINAC complex [CC], chromosome [CC], nBAF complex [CC], Mo-molybdopterin cofactor biosynthetic process [BP], histone deacetylase binding [MF], SWI/SNF complex [CC]
CG_adsipsc_promoter_n_RM_14_64_9	2	0.2	3.91E-04	TAF9, SAP130	STAGA complex [CC]
CG_adsipsc_promoter_n_RM_14_296_13	5	0.4	3.39E-04	DVL1, HOMER2, CHRNA3, GRIN3A	neurotransmitter binding [MF], neuronal cell body [CC], postsynaptic density [CC], prepulse inhibition [BP]
CG_adsipsc_promoter_n_RM_18_11_4	2	0.2	3.29E-04	CITED1, VDR, HEYL, DBN1	AF-1 domain binding [MF], vitamin D3 receptor activity [MF], cell communication by chemical coupling [BP], response to interleukin-11 [BP], transcription regulatory region DNA binding [MF]
CG_adsipsc_promoter_n_RM_12_30_8	5	0.8	2.01E-04	NRARP, IFNA2, DBN1	negative regulation of interleukin-5 secretion [BP], negative regulation of T cell differentiation [BP], cell communication by chemical coupling [BP], negative regulation of interleukin-13 secretion [BP]
CG_adsipsc_promoter_n_RM_14_62_8	10	0.8	4.11E-04	CALCOCO1, MED13L	RNA polymerase II transcription cofactor activity [MF], transcription cofactor activity [MF]
CG_adsipsc_promoter_n_RM_12_440_9	4	0.8	3.05E-04	GPC3	peptidyl-dipeptidase inhibitor activity [MF]
CG_adsipsc_promoter_n_RM_14_326_24	7	0.8	4.03E-04	PTK2, HSPA5, PLXNA2, EVX2, SMAD7, FBN2, ZFHX3, HOXB5, GLI3, FOXO1, PAX3, FOXN4, FOXI3, ALX4, HMX1	negative regulation of transforming growth factor beta receptor signaling pathway [BP], anatomical structure morphogenesis [BP], pattern specification process [BP], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], limb morphogenesis [BP], organ morphogenesis [BP], sequence-specific DNA binding transcription factor activity [MF], organ development [BP], sequence-specific DNA binding [MF], anterior/posterior pattern specification [BP], tissue development [BP], neural tube development [BP], embryo development [BP], transcription factor complex [CC], multicellular organismal development [BP], establishment of nucleus localization [BP], DNA binding, bending [MF]
CG_adsipsc_promoter_n_RM_12_204_28	7	1.0	2.88E-04	PRDX3	maternal placenta development [BP]
CG_adsipsc_promoter_n_RM_14_312_7	2	0.2	3.23E-04	ZFAT, RUNX1, HAND2, MESP1	peripheral nervous system neuron development [BP], hematopoietic progenitor cell differentiation [BP], cardiac ventricle formation [BP], heart looping [BP]
CG_adsipsc_promoter_n_RM_12_141_18	4	0.8	2.26E-04	UBXN7, GJA3, DLG4, TCF3, RPS6KA3, PCDH1, WHSC1L1, FOXA1, GLI3, PAX6, HSP90AA1, PTCH1, B9D1, MYH10	hedgehog receptor activity [MF], hindbrain development [BP], neuron fate commitment [BP], cell-cell signaling [BP], transcription factor binding [MF], axon guidance [BP], cell development [BP], glucose homeostasis [BP], neural tube patterning [BP], thymocyte apoptotic process [BP], smoothened signaling pathway [BP], negative regulation of alpha-beta T cell differentiation [BP], forebrain dorsal/ventral pattern formation [BP], neuron fate specification [BP], cell differentiation [BP], nervous system development [BP]
CG_adsipsc_promoter_n_RM_14_335_16	5	0.6	2.47E-04	TGFB1, NOXO1, APOA4	eukaryotic cell surface binding [MF], protein-lipid complex assembly [BP], superoxide metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_294_13	5	1.0	3.35E-04	NPC1, PTCH1, MNX1, BNIP3, CYP1A1	hedgehog receptor activity [MF], response to hyperoxia [BP], oxidoreductase activity, acting on diphenols and related substances as donors [MF], dorsal/ventral neural tube patterning [BP]
CG_adsipsc_promoter_n_RM_14_337_2	2	0.2	3.99E-04	HEG1, NCBP2, TCEA1, TAF4	lymph vessel development [BP], transcription elongation from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_14_25_12	2	0.4	3.34E-04	RICTOR, LRP6, FOXA2, EFNA5	primitive streak formation [BP], dopaminergic neuron differentiation [BP], gastrulation with mouth forming second [BP], regulation of Rac GTPase activity [BP], regulation of insulin secretion involved in cellular response to glucose stimulus [BP]
CG_adsipsc_promoter_n_RM_12_36_7	5	1.0	1.22E-04	NFS1	cysteine desulfurase activity [MF]
CG_adsipsc_promoter_n_RM_12_487_11	4	0.6	1.97E-04	RGPD8, RGPD3	protein targeting to Golgi [BP]
CG_adsipsc_promoter_n_RM_12_360_20	3	0.6	3.48E-04	CSPG4, ADCY3, HRAS, VAV2, NUP37, BAD, HS6ST1, APOA4, KCNB1, ADI1	nerve growth factor receptor signaling pathway [BP], small molecule metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_347_17	5	1.0	4.51E-04	NOC2L, PSIP1, NCBP2, CSPG5, SOX10, PAF1, RXRG, EZH1, ASCL2, HOXA4, NEUROG1, EZH2, PHLDA3, HOXA7	anatomical structure morphogenesis [BP], ESC/E(Z) complex [CC], peripheral nervous system development [BP], regulation of synaptic transmission [BP], stem cell differentiation [BP], negative regulation of epidermal cell differentiation [BP], chromatin binding [MF], mRNA cis splicing, via spliceosome [BP]
CG_adsipsc_promoter_n_RM_14_316_4	2	0.2	4.55E-04	PCSK1, ARHGEF3, CELSR1, TAX1BP3	Rho protein signal transduction [BP], peptide biosynthetic process [BP]
CG_adsipsc_promoter_n_RM_14_287_7	2	0.2	2.94E-04	ANAPC2, TUBGCP6, TUBGCP2	microtubule nucleation [BP], mitotic cell cycle spindle assembly checkpoint [BP]
CG_adsipsc_promoter_n_RM_14_101_19	4	0.8	4.90E-04	FBXW4, FGFR1, GAS1	outer ear morphogenesis [BP], positive regulation of mesenchymal cell proliferation [BP]
CG_adsipsc_promoter_n_RM_12_438_16	3	0.6	2.34E-04	NOTCH1, ZIC5, WNT5A, BBC3, NCOR1, NKX2-5, GNB1	cardiac septum morphogenesis [BP], ventricular trabecula myocardium morphogenesis [BP], regulation of cardiac muscle cell proliferation [BP], BMP signaling pathway [BP], heart looping [BP], negative regulation of myotube differentiation [BP], cardiac right atrium morphogenesis [BP], receptor tyrosine kinase-like orphan receptor binding [MF], prostate gland epithelium morphogenesis [BP], cardiac atrium morphogenesis [BP], negative regulation of canonical Wnt receptor signaling pathway [BP], cardiac muscle cell apoptotic process [BP], cardiac muscle tissue morphogenesis [BP], positive regulation of thymocyte apoptotic process [BP], atrioventricular node development [BP], cardiac ventricle formation [BP], heart trabecula morphogenesis [BP], transcription regulatory region DNA binding [MF], heart morphogenesis [BP], pericardium morphogenesis [BP], embryonic heart tube development [BP], canonical Wnt receptor signaling pathway [BP], ventricular septum morphogenesis [BP], negative regulation of BMP signaling pathway [BP], cardiac conduction system development [BP], RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription [MF], determination of left/right symmetry [BP], cardiac muscle cell proliferation [BP], forebrain development [BP], cardiac chamber formation [BP], cellular response to hypoxia [BP], neural tube development [BP], transcription initiation from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_492_14	5	0.6	3.04E-04	NFIB, TESC, CTBP1	megakaryocyte differentiation [BP], RNA polymerase II transcription corepressor activity [MF]
CG_adsipsc_promoter_n_RM_12_31_11	5	1.0	2.76E-04	ADAMTS9, PCSK6, BCL2, FADS1	positive regulation of melanocyte differentiation [BP], zygotic determination of anterior/posterior axis, embryo [BP], response to sucrose stimulus [BP]
CG_adsipsc_promoter_n_RM_18_13_2	2	0.4	3.93E-04	TNFRSF10D, PITX1	TRAIL binding [MF], myoblast cell fate commitment [BP], branchiomeric skeletal muscle development [BP]
CG_adsipsc_promoter_n_RM_12_32_6	2	0.4	2.74E-04	GRM4	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway [BP], presynaptic active zone membrane [CC]
CG_adsipsc_promoter_n_RM_14_238_5	1	0.2	3.51E-04	RUNX1, WNT10B, LSS, MEX3D	positive regulation of anagen [BP], myoblast cell differentiation involved in skeletal muscle regeneration [BP], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], positive regulation of progesterone secretion [BP], lanosterol synthase activity [MF], hematopoietic stem cell proliferation [BP]
CG_adsipsc_promoter_n_RM_12_49_23	6	1.0	2.84E-04	STAT1, EGR3, LAMB1, MAP3K7, SIX1, NACC2, FOXO1, CXCR4, SHH, FGF4, NRP1, LAMA5	angiogenesis [BP], patterning of blood vessels [BP], branching involved in salivary gland morphogenesis [BP], positive regulation of epithelial cell proliferation [BP], metanephric mesenchymal cell proliferation involved in metanephros development [BP], renal tubule development [BP], ureter smooth muscle cell differentiation [BP], endothelial cell chemotaxis [BP], odontogenesis [BP], positive regulation of mesenchymal cell proliferation [BP], positive regulation of mesenchymal cell proliferation involved in ureter development [BP], positive regulation of oligodendrocyte differentiation [BP], positive regulation of cell proliferation [BP], metanephric mesenchyme development [BP], mesenchymal cell proliferation [BP], laminin-10 complex [CC], tissue development [BP], blood vessel development [BP], laminin-1 complex [CC], branching morphogenesis of an epithelial tube [BP]
CG_adsipsc_promoter_n_RM_14_80_17	4	0.6	4.92E-04	TFAP2A, AMBRA1, MAP3K5, HOXA7, LATS1, FOXM1, SAV1, NCKAP1, PRPSAP1	positive regulation of apoptotic process [BP], negative regulation of cell aging [BP], embryonic body morphogenesis [BP], intestinal epithelial cell differentiation [BP], keratinocyte differentiation [BP], stem cell differentiation [BP], kinase binding [MF]
CG_adsipsc_promoter_n_RM_14_248_11	3	0.4	3.76E-04	DPYD, PSIP1	supercoiled DNA binding [MF], dihydropyrimidine dehydrogenase (NADP+) activity [MF]
CG_adsipsc_promoter_n_RM_12_392_16	4	0.8	2.73E-04	HDAC4, HMGB1, NCOR1, SMEK2, FOXO1	transcriptional repressor complex [CC], positive regulation of gluconeogenesis [BP]
CG_adsipsc_promoter_n_RM_14_21_6	1	0.2	4.11E-04	CYP7B1, APBA1, ESR2	cell death [BP], glutamate secretion [BP], prostate gland epithelium morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_46_15	4	0.8	2.46E-04	AGTPBP1, NKX3-1, TTLL6	MADS box domain binding [MF], tubulin binding [MF]
CG_adsipsc_promoter_n_RM_14_218_8	4	0.4	2.80E-04	LAMA5	embryo development [BP]
CG_adsipsc_promoter_n_RM_14_251_4	2	0.2	2.85E-04	BID, BBC3	positive regulation of protein oligomerization [BP], establishment of protein localization to membrane [BP], positive regulation of release of cytochrome c from mitochondria [BP], positive regulation of protein homooligomerization [BP], regulation of mitochondrial membrane permeability [BP], release of cytochrome c from mitochondria [BP]
CG_adsipsc_promoter_n_RM_12_6_14	3	0.6	3.28E-04	MESP1	negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], cardiac atrium formation [BP], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], sinus venosus morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_132_2	2	0.4	3.13E-04	ACVR1C, PTCH1	negative regulation of chorionic trophoblast cell proliferation [BP], activin receptor complex [CC], neural plate axis specification [BP], nodal binding [MF], response to chlorate [BP]
CG_adsipsc_promoter_n_RM_12_216_33	6	0.8	3.99E-04	ESR2, STAT1, EVX2, HOXA7, STAT5B, IRX4, NEUROG2, SOX3, PAX8, HOXA2, MKX, GAMT	mesenchymal to epithelial transition involved in metanephros morphogenesis [BP], RNA polymerase II core promoter sequence-specific DNA binding [MF], transcription regulatory region DNA binding [MF], organ morphogenesis [BP], regulation of metanephric nephron tubule epithelial cell differentiation [BP], sequence-specific DNA binding [MF], core promoter sequence-specific DNA binding [MF], creatine metabolic process [BP], regulation of epithelial cell differentiation [BP]
CG_adsipsc_promoter_n_RM_12_232_14	5	0.6	3.03E-04	LMF1, GRIN2A, SLC6A4, NETO1	regulation of cholesterol metabolic process [BP], memory [BP], myosin binding [MF]
CG_adsipsc_promoter_n_RM_12_340_9	3	0.6	2.62E-04	SLC2A14, SLC2A1, BCL2, SLC4A7	cochlear nucleus development [BP], retinal cell programmed cell death [BP], glucose transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_14_27_9	4	0.6	2.80E-04	SYT7	regulation of calcium ion-dependent exocytosis [BP]
CG_adsipsc_promoter_n_RM_14_353_11	3	0.4	2.85E-04	PYCARD, STAT5B	positive regulation of activated T cell proliferation [BP]
CG_adsipsc_promoter_n_RM_12_354_9	3	0.6	3.10E-04	ACVR1, TBX3, CADPS2	cardiac muscle cell fate commitment [BP], synaptic vesicle priming [BP]
CG_adsipsc_promoter_n_RM_12_365_12	4	0.6	1.61E-04	NPHP4, TEAD3	hippo signaling cascade [BP]
CG_adsipsc_promoter_n_RM_12_339_19	4	0.6	2.84E-04	CCBE1, HEG1	venous blood vessel morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_216_7	2	0.2	2.83E-04	UCN, PARD3, CCDC90A	calcium ion import [BP], neuron projection development [BP], wound healing, spreading of cells [BP]
CG_adsipsc_promoter_n_RM_12_315_17	5	0.8	3.09E-04	LINGO1, ADCY3, FRS3, PRKACG, PRKACA, FGF20, RALGDS	cAMP-dependent protein kinase activity [MF], activation of protein kinase A activity [BP], nerve growth factor receptor signaling pathway [BP], fibroblast growth factor receptor signaling pathway [BP], cellular response to glucagon stimulus [BP], activation of phospholipase C activity [BP], water transport [BP]
CG_adsipsc_promoter_n_RM_12_48_19	6	1.0	3.66E-04	CD320, MAD2L2	regulation of cell growth [BP]
CG_adsipsc_promoter_n_RM_12_188_11	3	0.4	2.53E-04	WNT5A, NOTCH1, SIAH2, PDGFA	cellular response to transforming growth factor beta stimulus [BP], cardiac right atrium morphogenesis [BP], negative regulation of canonical Wnt receptor signaling pathway [BP], pericardium morphogenesis [BP], lung development [BP], negative chemotaxis [BP], respiratory system development [BP]
CG_adsipsc_promoter_n_RM_14_375_6	3	0.4	3.51E-04	WDR24, KIF17, KIFC3, PEX1	kinesin complex [CC], protein import into peroxisome matrix [BP], protein targeting to peroxisome [BP]
CG_adsipsc_promoter_n_RM_12_28_25	3	0.6	3.17E-04	CHKA	choline kinase activity [MF]
CG_adsipsc_promoter_n_RM_16_14_2	4	0.4	1.63E-04	PAX6, HDDC3, TSHZ3	guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], ureteric peristalsis [BP], commitment of neuronal cell to specific neuron type in forebrain [BP], regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP], pancreatic A cell development [BP], forebrain-midbrain boundary formation [BP]
CG_adsipsc_promoter_n_RM_14_231_7	2	0.2	3.29E-04	NAGA, HID1	response to brefeldin A [BP], alpha-N-acetylgalactosaminidase activity [MF], extrinsic to Golgi membrane [CC]
CG_adsipsc_promoter_n_RM_12_480_12	4	0.8	2.58E-04	GTF2E2, IRF7, DERL1, HLA-C, ASH1L, HSPD1, ZSCAN29, CUL7, ATXN1, XPO1	interferon-alpha production [BP], early endosome [CC], nuclear export [BP], viral reproduction [BP], positive regulation of interferon-alpha production [BP], virus-host interaction [BP], transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_14_233_6	2	0.2	3.61E-04	SLC16A8, KCNE1, ADAM10	lactate transmembrane transport [BP], constitutive protein ectodomain proteolysis [BP], lactate transmembrane transporter activity [MF], lactate transport [BP], positive regulation of potassium ion transmembrane transport [BP]
CG_adsipsc_promoter_n_RM_16_16_5	4	0.4	2.45E-04	SLC25A11, L2HGDH	2-hydroxyglutarate dehydrogenase activity [MF], oxoglutarate:malate antiporter activity [MF]
CG_adsipsc_promoter_n_RM_14_138_9	3	0.4	1.71E-04	LHX6, EPC1, ACTB	forebrain neuron fate commitment [BP], NuA4 histone acetyltransferase complex [CC]
CG_adsipsc_promoter_n_RM_12_388_9	3	0.6	1.61E-04	NCOR2, JAK3	negative regulation of FasL biosynthetic process [BP], regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_328_12	2	0.4	1.85E-04	STRA13, TONSL	replication fork processing [BP]
CG_adsipsc_promoter_n_RM_12_341_16	3	0.6	2.96E-04	CEBPA, HOXA10, ECI1, WIF1, ELOVL2, FASN, FBN1, SFRP2	positive regulation of fat cell differentiation [BP], fatty acid synthase activity [MF], intramolecular oxidoreductase activity [MF], triglyceride biosynthetic process [BP], skeletal system development [BP]
CG_adsipsc_promoter_n_RM_14_28_7	1	0.2	3.37E-04	CDK6, FBXO31, PSMB1	cyclin binding [MF], cell dedifferentiation [BP], G1/S transition of mitotic cell cycle [BP]
CG_adsipsc_promoter_n_RM_12_151_16	4	0.8	4.03E-04	WNK3, SCN4B, ABCA2, ABCF2, SLC23A1	positive regulation of sodium ion transport [BP], ATP-binding cassette (ABC) transporter complex [CC], sodium ion transmembrane transport [BP], membrane depolarization involved in regulation of cardiac muscle cell action potential [BP]
CG_adsipsc_promoter_n_RM_14_318_5	2	0.2	5.70E-04	GCLC, LONP1	ADP binding [MF]
CG_adsipsc_promoter_n_RM_12_138_16	8	1.0	3.02E-04	C1orf86, VCP	translesion synthesis [BP]
CG_adsipsc_promoter_n_RM_12_383_24	6	1.0	3.26E-04	BMP4, CIZ1, VAV2, PTCH1, HOXA1, LEF1, JAG1, TNK2	cyclin binding [MF], artery development [BP], trachea development [BP], epidermal growth factor receptor binding [MF], cell migration [BP], sprouting angiogenesis [BP], artery morphogenesis [BP], inner ear development [BP], somite development [BP], negative regulation of striated muscle tissue development [BP], pulmonary artery morphogenesis [BP], dorsal/ventral neural tube patterning [BP]
CG_adsipsc_promoter_n_RM_12_197_17	2	0.4	1.53E-04	RORA	cGMP metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_488_7	3	0.6	3.57E-04	UBC	energy homeostasis [BP]
CG_adsipsc_promoter_n_RM_16_10_3	1	0.2	1.84E-04	PNPLA8, NACC2	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], phosphatidylethanolamine catabolic process [BP]
CG_adsipsc_promoter_n_RM_12_403_10	2	0.2	3.78E-04	SLC30A1, DLG4, SSBP3	P2Y1 nucleotide receptor binding [MF], prechordal plate formation [BP], midbrain-hindbrain boundary initiation [BP], negative regulation of zinc ion transmembrane import [BP]
CG_adsipsc_promoter_n_RM_14_14_6	2	0.2	4.20E-04	SLC35B2	3'-phosphoadenosine 5'-phosphosulfate transport [BP], 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_14_390_5	1	0.2	4.27E-04	NPC1, RNF168, INSRR, GCNT4	cholesterol efflux [BP], cellular response to alkalinity [BP], inter-male aggressive behavior [BP], histone H2A-K15 ubiquitination [BP], histone H2A-K13 ubiquitination [BP]
CG_adsipsc_promoter_n_RM_12_202_13	6	1.0	3.80E-04	TCEA1, MAP3K5	apoptotic signaling pathway [BP], erythrocyte differentiation [BP]
CG_adsipsc_promoter_n_RM_12_267_16	3	0.4	1.47E-04	SALL1, HAND2, SPAG8, NRP1, KIF7	sympathetic nervous system development [BP], positive regulation of protein binding [BP], negative regulation of smoothened signaling pathway [BP], semaphorin-plexin signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_376_16	3	0.6	4.12E-04	MTSS1, STAT1, FGFR1, WNT7B	nephron tubule epithelial cell differentiation [BP], lung-associated mesenchyme development [BP], renal tubule development [BP]
CG_adsipsc_promoter_n_RM_12_246_5	6	1.0	2.62E-04	HNRPDL, PCGF6, NFE2L2, MCM9, ZFP36L1, MAMSTR, GNB2L1, MAPK1, REV3L, ZBTB45, ELMSAN1, POLR2L, BBC3, CBX4, FAM200A, PROX2, GTF2A1, PCGF2	nucleic acid binding [MF], PcG protein complex [CC], PRC1 complex [CC], DNA binding [MF], positive regulation of protein homooligomerization [BP]
CG_adsipsc_promoter_n_RM_14_167_4	1	0.2	2.57E-04	HOXB5, TBX18	positive regulation of cell-cell adhesion [BP], anatomical structure morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_386_6	3	0.4	2.54E-04	KCNB1, KCNA3, TUBGCP6, ASPM	spindle pole [CC], outward rectifier potassium channel activity [MF]
CG_adsipsc_promoter_n_RM_14_276_5	2	0.2	3.75E-04	NFATC2, DUOX2, BCAR1, BID, ALDH4A1	establishment of protein localization to membrane [BP], B cell receptor signaling pathway [BP], 1-pyrroline-5-carboxylate dehydrogenase activity [MF], adenohypophysis morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_401_10	7	0.8	2.71E-04	CBS, PLLP, HSPG2, AKT1, PSMA7, CDK6, BCAR1, GSPT1	positive regulation of blood vessel endothelial cell migration [BP], osteoblast differentiation [BP], G1/S transition of mitotic cell cycle [BP], positive regulation of endothelial cell migration [BP], endochondral ossification [BP], cartilage development involved in endochondral bone morphogenesis [BP], myelination [BP]
CG_adsipsc_promoter_n_RM_12_486_9	4	0.6	2.66E-04	OBSL1, ACTC1	cardiac myofibril assembly [BP]
CG_adsipsc_promoter_n_RM_14_199_5	3	0.2	2.86E-04	MECP2, PHOX2A	cerebellum development [BP], regulation of respiratory gaseous exchange [BP]
CG_adsipsc_promoter_n_RM_12_187_7	4	0.6	1.38E-04	IRS2, CLTCL1	positive regulation of glucose import [BP]
CG_adsipsc_promoter_n_RM_12_309_12	4	0.8	2.73E-04	AXIN1, SMAD7	I-SMAD binding [MF]
CG_adsipsc_promoter_n_RM_12_366_20	5	0.8	2.62E-04	JUN, COMMD7, EN1, FOXL2, CDK5, PHB, IGF2BP3, TSHZ3	negative regulation of transcription, DNA-dependent [BP], anatomical structure morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_111_13	4	0.6	2.23E-04	ROR2, WNT7A	frizzled binding [MF]
CG_adsipsc_promoter_n_RM_14_84_18	10	0.8	3.24E-04	PTCH1, FZD8	brain development [BP]
CG_adsipsc_promoter_n_RM_12_24_17	5	0.6	2.33E-04	PLOD3, AMBRA1, SALL1, GLI3, BCL2L1	neural tube development [BP], regulation of mitochondrial membrane potential [BP], negative regulation of smoothened signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_389_12	4	0.8	2.14E-04	MYH9, BCAR1, DIAPH1, DBN1	profilin binding [MF], ruffle [CC]
CG_adsipsc_promoter_n_RM_14_130_5	3	0.2	4.30E-04	EPHA1, PEAK1, PASK	substrate adhesion-dependent cell spreading [BP], protein autophosphorylation [BP]
CG_adsipsc_promoter_n_RM_14_259_13	2	0.2	3.33E-04	ZBTB7A, GLI3	histone acetyltransferase binding [MF]
CG_adsipsc_promoter_n_RM_12_476_12	4	0.8	1.86E-04	PIEZO2, KIF5B, PIEZO1, CLIP3	mechanically-gated ion channel activity [MF], positive regulation of establishment of protein localization to plasma membrane [BP]
CG_adsipsc_promoter_n_RM_12_135_23	6	1.0	3.55E-04	CENPC1, POGZ	kinetochore assembly [BP]
CG_adsipsc_promoter_n_RM_12_265_21	3	0.6	1.64E-04	TCF3, SUPT3H, TADA1	histone H3 acetylation [BP], STAGA complex [CC]
CG_adsipsc_promoter_n_RM_12_125_8	8	1.0	2.66E-04	BAD	ADP metabolic process [BP]
CG_adsipsc_promoter_n_RM_14_313_7	1	0.2	3.11E-04	WNT7B	establishment or maintenance of polarity of embryonic epithelium [BP], outer medullary collecting duct development [BP]
CG_adsipsc_promoter_n_RM_14_117_11	3	0.4	2.61E-04	HEY1, HS6ST1	labyrinthine layer blood vessel development [BP]
CG_adsipsc_promoter_n_RM_12_199_14	6	1.0	2.72E-04	NUP62, TFAP4, GLI3, NOTCH1, EN1, FOXA2, TAF4, NKX2-2, SOST	oligodendrocyte differentiation [BP], digestive tract development [BP], oligodendrocyte cell fate commitment [BP], positive regulation of transcription, DNA-dependent [BP], glial cell differentiation [BP], negative regulation of neuron differentiation [BP], cell fate specification [BP], neuron fate specification [BP], dorsal/ventral pattern formation [BP], neural tube development [BP]
CG_adsipsc_promoter_n_RM_12_260_10	2	0.4	3.00E-04	PLA2R1, BMP4, DGKQ, HOXB5, TFAP2A	embryonic skeletal system morphogenesis [BP], lens induction in camera-type eye [BP], phospholipase binding [MF]
CG_adsipsc_promoter_n_RM_12_306_11	3	0.6	2.24E-04	TRIT1, PABPC1, TRPV4	osmosensor activity [MF], cortical microtubule organization [BP], osmosensory signaling pathway [BP], tRNA dimethylallyltransferase activity [MF], negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP]
CG_adsipsc_promoter_n_RM_12_432_5	1	0.2	2.26E-04	PPIL6, PPIL1	peptidyl-prolyl cis-trans isomerase activity [MF]
CG_adsipsc_promoter_n_RM_12_434_8	3	0.6	2.87E-04	BARHL2, SATB2	histone deacetylase complex [CC], neuron migration [BP]
CG_adsipsc_promoter_n_RM_12_60_6	9	1.0	2.66E-04	NCR3, STAT5B	positive regulation of natural killer cell mediated cytotoxicity [BP]
CG_adsipsc_promoter_n_RM_12_153_15	2	0.4	2.52E-04	ALG3, GHSR, LRRC4B, WNT7A, ALG2	synapse organization [BP], regulation of synapse assembly [BP], alpha-1,3-mannosyltransferase activity [MF], positive regulation of synapse assembly [BP], negative regulation of neurogenesis [BP]
CG_adsipsc_promoter_n_RM_14_196_9	1	0.2	2.89E-04	CBS	cysteine biosynthetic process via cystathionine [BP], cystathionine beta-synthase activity [MF], cysteine biosynthetic process from serine [BP], homocysteine catabolic process [BP]
CG_adsipsc_promoter_n_RM_12_175_15	2	0.4	2.44E-04	CDK4	positive regulation of cell size [BP]
CG_adsipsc_promoter_n_RM_12_107_3	2	0.4	2.19E-04	C5, SFRP1	stromal-epithelial cell signaling involved in prostate gland development [BP], positive regulation of fibroblast apoptotic process [BP], negative regulation of macrophage chemotaxis [BP], convergent extension involved in somitogenesis [BP], negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP]
CG_adsipsc_promoter_n_RM_12_380_14	2	0.2	2.97E-04	SOX21, KLF10, GLIS1, GSC2, TRAF6, TBX20, NR2F6, TFCP2L1, CDC37, ABCA2, DACH1, CBX4, SOX7, FOXN3, MAD2L2	sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], negative regulation of transcription by competitive promoter binding [BP], negative regulation of transcription from RNA polymerase II promoter [BP], positive regulation of osteoclast differentiation [BP], negative regulation of transcription, DNA-dependent [BP], protein kinase B binding [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_93_5	2	0.2	3.60E-04	BTC, YES1	epidermal growth factor receptor binding [MF]
CG_adsipsc_promoter_n_RM_12_474_10	6	1.0	3.00E-04	CNOT7, ZFP36L2, PGM3, EXD3, HAND2, EXOSC3, EXOSC6, NFIB	glucosamine metabolic process [BP], 3'-5' exonuclease activity [MF], DNA deamination [BP], nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [BP], negative regulation of DNA binding [BP]
CG_adsipsc_promoter_n_RM_16_36_2	1	0.2	6.56E-04	TRIM27, IMPDH1, BMP7	nephrogenic mesenchyme morphogenesis [BP], negative regulation of interleukin-2 secretion [BP], IMP dehydrogenase activity [MF]
CG_adsipsc_promoter_n_RM_12_8_7	5	0.8	1.84E-04	GNB1, NR3C1, MBOAT4, RPS6KA2	cardiac muscle cell apoptotic process [BP], glucocorticoid receptor activity [MF], peptidyl-serine octanoylation [BP], serine O-acyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_282_4	2	0.2	3.36E-04	NIN, SEMA6A, EGR3	centrosome localization [BP], cellular response to vascular endothelial growth factor stimulus [BP]
CG_adsipsc_promoter_n_RM_14_192_5	2	0.2	2.12E-04	WNK3, PDGFRB	cell migration involved in coronary angiogenesis [BP], positive regulation of rubidium ion transport [BP], positive regulation of rubidium ion transmembrane transporter activity [BP]
CG_adsipsc_promoter_n_RM_14_168_11	7	1.0	3.82E-04	KLF10, SNTB1, HMGB2, SP3, TFEB, ALX4, RUNX1, TMEM229A, POU3F1	myeloid cell differentiation [BP], sequence-specific DNA binding transcription factor activity [MF], definitive hemopoiesis [BP], protein complex [CC]
CG_adsipsc_promoter_n_RM_20_5_1	1	0.2	8.21E-04	HIST1H2BJ, HIST1H2AK, HIST1H1T	nucleosome assembly [BP], nucleosome [CC]
CG_adsipsc_promoter_n_RM_14_149_6	2	0.2	3.12E-04	HBEGF	negative regulation of elastin biosynthetic process [BP]
CG_adsipsc_promoter_n_RM_14_91_6	3	0.4	2.87E-04	TEX10, CHD8	MLL1 complex [CC]
CG_adsipsc_promoter_n_RM_14_144_16	10	1.0	2.62E-04	RPUSD3, PUS7L	pseudouridine synthase activity [MF]
CG_adsipsc_promoter_n_RM_12_116_12	5	0.6	2.99E-04	PLXNA2, MED14, NKX3-1, FOXA1	pharyngeal system development [BP], intracellular steroid hormone receptor signaling pathway [BP], prostate gland epithelium morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_327_10	7	0.8	4.11E-04	BCL11A, CLU	negative regulation of protein homooligomerization [BP]
CG_adsipsc_promoter_n_RM_14_229_5	2	0.2	3.40E-04	DBR1, NKX3-1, MYO1C	positive regulation of androgen secretion [BP], MADS box domain binding [MF], myosin I complex [CC], RNA lariat debranching enzyme activity [MF], positive regulation of vascular endothelial growth factor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_14_97_5	2	0.2	2.81E-04	HSPA8, HSP90AA1	response to unfolded protein [BP]
CG_adsipsc_promoter_n_RM_14_388_6	5	0.6	4.50E-04	APBB1, HOXB5, CHMP1A	negative regulation of S phase of mitotic cell cycle [BP], anterior/posterior pattern specification [BP]
CG_adsipsc_promoter_n_RM_12_180_9	5	0.8	2.12E-04	RANGAP1, ADI1	acireductone dioxygenase [iron(II)-requiring] activity [MF], Ran GTPase activator activity [MF]
CG_adsipsc_promoter_n_RM_14_155_11	3	0.4	3.22E-04	PAX6	forebrain-midbrain boundary formation [BP], commitment of neuronal cell to specific neuron type in forebrain [BP], pancreatic A cell development [BP], regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP]
CG_adsipsc_promoter_n_RM_14_286_7	5	0.8	4.05E-04	TNR, SCFD2	synapse organization [BP], vesicle docking involved in exocytosis [BP]
CG_adsipsc_promoter_n_RM_12_105_8	4	0.6	2.81E-04	POU4F1, MTMR6, ARF3, CNTFR	phosphatidylinositol biosynthetic process [BP], phospholipid metabolic process [BP], suckling behavior [BP]
CG_adsipsc_promoter_n_RM_12_147_20	2	0.4	2.00E-04	SHC3, HLA-C, HLA-B, BAD, EPS15L1, FMNL3, PLXNB1	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP], epidermal growth factor receptor signaling pathway [BP], GTPase activating protein binding [MF]
CG_adsipsc_promoter_n_RM_12_166_11	4	0.8	2.95E-04	BBC3, ABCB6, AIFM2	mitochondrial outer membrane [CC]
CG_adsipsc_promoter_n_RM_14_180_13	3	0.2	4.27E-04	TAL1, TBX18	hemangioblast cell differentiation [BP], Lsd1/2 complex [CC], negative regulation of canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP]
CG_adsipsc_promoter_n_RM_12_112_20	7	1.0	3.07E-04	GRM6, PLXNB2	neuroblast proliferation [BP], adenylate cyclase inhibiting G-protein coupled glutamate receptor activity [MF]
CG_adsipsc_promoter_n_RM_14_382_3	2	0.2	4.24E-04	RAD21	reciprocal meiotic recombination [BP]
CG_adsipsc_promoter_n_RM_14_349_6	1	0.2	2.33E-04	NMUR1, PCSK1N, NPPC, GATM	glycine amidinotransferase activity [MF], creatine biosynthetic process [BP], neuropeptide signaling pathway [BP], regulation of multicellular organism growth [BP]
CG_adsipsc_promoter_n_RM_12_322_8	2	0.4	3.04E-04	DUSP10, DUSP18, CBS	MAP kinase phosphatase activity [MF], regulation of JUN kinase activity [BP], MAP kinase tyrosine/serine/threonine phosphatase activity [MF], cerebellum morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_329_10	2	0.2	4.17E-04	ICMT, AGO2	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], endoribonuclease activity, cleaving siRNA-paired mRNA [MF]
CG_adsipsc_promoter_n_RM_14_289_6	5	0.8	3.30E-04	LEF1, TJP1, CLMP, KDELR2	tight junction [CC], KDEL sequence binding [MF], negative regulation of estrogen receptor binding [BP], formation of radial glial scaffolds [BP], negative regulation of interleukin-13 production [BP], cell-cell signaling involved in cell-cell junction organization [BP], response to magnetism [BP], muscle fiber development [BP], odontoblast differentiation [BP], negative regulation of apoptotic process in bone marrow [BP], trachea gland development [BP], positive regulation of cell proliferation in bone marrow [BP], apical junction complex [CC]
CG_adsipsc_promoter_n_RM_20_3_1	1	0.2	3.23E-05	ZNF564, ZNF799, ZNF433, ZNF443, ZNF709	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_adsipsc_promoter_n_RM_14_93_3	2	0.2	2.78E-04	ATXN1, HRAS	visual learning [BP]
CG_adsipsc_promoter_n_RM_14_362_3	1	0.2	4.38E-04	LCAT, ABCB6, SLC25A11, AGO2, HNF1B	phosphatidylcholine-sterol O-acyltransferase activity [MF], heme-transporting ATPase activity [MF], endoribonuclease activity, cleaving siRNA-paired mRNA [MF], regulation of pronephros size [BP], oxoglutarate:malate antiporter activity [MF]
CG_adsipsc_promoter_n_RM_14_211_6	2	0.2	2.39E-04	JAK3, AKT1	T cell homeostasis [BP], negative regulation of FasL biosynthetic process [BP], glycogen cell differentiation involved in embryonic placenta development [BP]
CG_adsipsc_promoter_n_RM_12_310_20	4	0.6	3.16E-04	SALL1, SMAD2, PAX6	co-SMAD binding [MF], regulation of neural precursor cell proliferation [BP]
CG_adsipsc_promoter_n_RM_12_412_9	2	0.4	3.07E-04	ZNF782, APLN, IRX3, HIVEP3, ARGLU1	transcription, DNA-dependent [BP], apelin receptor binding [MF]
CG_adsipsc_promoter_n_RM_12_372_30	5	0.8	4.61E-04	MESP1, OAT, ITPK1	inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF], negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], cardiac atrium formation [BP], ornithine-oxo-acid transaminase activity [MF], inositol tetrakisphosphate 1-kinase activity [MF], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], sinus venosus morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_291_16	4	0.6	3.04E-04	SOX18, GSC2, HOXB5, GAS1	cell fate commitment [BP], establishment of endothelial barrier [BP], anatomical structure morphogenesis [BP], endothelial cell differentiation [BP]
CG_adsipsc_promoter_n_RM_12_37_8	3	0.4	3.05E-04	FOXJ1, HDAC4, TCF3, ZNF425, SIX5, TAF13, SREBF1, ZFP30, CALCOCO1, ZNF214, POLN, EDF1	sequence-specific DNA binding [MF], transcription factor TFIID complex [CC], DNA binding [MF], transcription regulatory region DNA binding [MF]
CG_adsipsc_promoter_n_RM_14_366_6	3	0.4	2.40E-04	LRP4, MEX3B, CDC42BPG, HYAL2, DNMBP, YWHAG, L2HGDH	protein domain specific binding [MF], protein phosphorylation [BP], 2-hydroxyglutarate dehydrogenase activity [MF], receptor signaling protein tyrosine kinase inhibitor activity [MF], receptor tyrosine kinase binding [MF]
CG_adsipsc_promoter_n_RM_14_347_4	2	0.2	3.15E-04	PIEZO1, MPPE1	endoplasmic reticulum-Golgi intermediate compartment membrane [CC]
CG_adsipsc_promoter_n_RM_14_332_11	4	0.4	3.58E-04	STRBP, DDIT3, ZNF232, STRN4, DNASE1L1, KLLN, HNRNPU, RFX2, LCORL, TAF11, ZNF425, ZNF787, ZNF846, LYL1, MAFA, EVX2, NHEJ1, ANKLE2, BCL2, SP8	DNA binding [MF], protein phosphatase 2A binding [MF]
CG_adsipsc_promoter_n_RM_14_212_19	4	0.4	2.47E-04	MYH10	cerebellar Purkinje cell layer development [BP]
CG_adsipsc_promoter_n_RM_14_345_11	2	0.2	3.54E-04	FZD4	cerebellum vasculature morphogenesis [BP]
CG_adsipsc_promoter_n_RM_16_30_7	2	0.2	5.13E-04	FZD8, PPP2CA, BHLHE23, BCL11B, TCF15, TWIST1, IMPAD1, CITED2, TRIP12, FGFR2, BSCL2, NR3C1	cell death [BP], bone development [BP], regulation of gluconeogenesis [BP], post-embryonic development [BP], protein dimerization activity [MF], death [BP], regulation of lipid metabolic process [BP], skeletal system morphogenesis [BP], bone morphogenesis [BP], cranial suture morphogenesis [BP], outflow tract morphogenesis [BP], negative regulation of double-strand break repair [BP], T cell differentiation in thymus [BP], mesenchymal cell differentiation [BP], cardiac neural crest cell development involved in heart development [BP]
CG_adsipsc_promoter_n_RM_20_9_2	1	0.2	4.25E-04	STAR, SLC26A1, STC1	response to fungicide [BP], cellular response to glucocorticoid stimulus [BP], fractalkine metabolic process [BP], oxalate transmembrane transporter activity [MF], cellular response to epinephrine stimulus [BP], cellular response to luteinizing hormone stimulus [BP], insecticide metabolic process [BP], response to nutrient [BP], cellular response to cAMP [BP]
CG_adsipsc_promoter_n_RM_12_3_14	4	0.6	3.76E-04	RARRES2, BNIP3, BRF1	transcription factor TFIIIB complex [CC], brown fat cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_372_7	2	0.2	3.01E-04	SIN3A, EEA1	response to methylglyoxal [BP], synaptic vesicle to endosome fusion [BP], serine-pyruvate aminotransferase complex [CC], negative regulation of histone H3-K27 acetylation [BP]
CG_adsipsc_promoter_n_RM_12_240_11	3	0.6	2.62E-04	IMMP2L, CLIP1	mitochondrial inner membrane peptidase complex [CC], macropinosome [CC]
CG_adsipsc_promoter_n_RM_12_178_15	4	0.6	3.64E-04	SLC33A1, ALDH9A1	4-trimethylammoniobutyraldehyde dehydrogenase activity [MF], acetyl-CoA transporter activity [MF], aminobutyraldehyde dehydrogenase activity [MF], acetyl-CoA transport [BP], 1-pyrroline dehydrogenase activity [MF]
CG_adsipsc_promoter_n_RM_12_317_6	6	0.8	1.31E-04	MGAT1	alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_adsipsc_promoter_n_RM_12_467_17	5	1.0	3.32E-04	CHST9	chondroitin sulfate metabolic process [BP]
CG_adsipsc_promoter_n_RM_16_39_3	2	0.4	9.86E-04	HIST3H2A, HIST1H1B, H2AFX	nucleosome assembly [BP], nucleosome [CC], nuclear chromatin [CC]
CG_adsipsc_promoter_n_RM_12_416_7	2	0.4	2.07E-04	COL1A1, MKX	collagen fibril organization [BP], collagen biosynthetic process [BP]
CG_adsipsc_promoter_n_RM_12_33_9	4	0.8	2.46E-04	BAG6	negative regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_adsipsc_promoter_n_RM_16_1_2	2	0.2	3.03E-04	DMGDH	dimethylglycine dehydrogenase activity [MF]
CG_adsipsc_promoter_n_RM_12_119_13	2	0.4	2.08E-04	MAP3K9, CARD9, FOXL2, FGF8, PYCARD, RNF216, BCAP31	positive regulation of cysteine-type endopeptidase activity [BP], regulation of intrinsic apoptotic signaling pathway [BP], positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP], regulation of interferon-beta production [BP], regulation of defense response to virus by host [BP], positive regulation of interleukin-6 production [BP], defense response to virus [BP], positive regulation of tumor necrosis factor production [BP], apoptotic process [BP]
CG_adsipsc_promoter_n_RM_14_280_7	2	0.4	4.71E-04	TBC1D10A, ADCY3, GNG4	guanyl-nucleotide exchange factor activity [MF], cellular response to glucagon stimulus [BP]
CG_adsipsc_promoter_n_RM_14_133_2	1	0.2	5.56E-04	EEA1	synaptic vesicle to endosome fusion [BP], serine-pyruvate aminotransferase complex [CC]
CG_adsipsc_promoter_n_RM_16_31_2	1	0.2	4.01E-04	PGM2L1, SMARCC1, SLC19A2, SMARCC2	thiamine transmembrane transport [BP], npBAF complex [CC], nBAF complex [CC], glucose-1,6-bisphosphate synthase activity [MF], chromatin remodeling [BP], nucleosome disassembly [BP], thiamine transport [BP], SWI/SNF complex [CC]
CG_adsipsc_promoter_n_RM_12_128_22	2	0.2	2.37E-04	DVL1, RAB3A, NGF	response to electrical stimulus [BP], clathrin-coated vesicle [CC], Wnt receptor signaling pathway, planar cell polarity pathway [BP], neurotransmitter secretion [BP], regulation of neurotransmitter levels [BP], positive regulation of Wnt receptor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_318_15	5	1.0	3.86E-04	NR4A2, HMGB2, SF3B1, REXO1, FOXM1, MCL1, ZXDA, RP9, ZNF746, CEBPA, CHD6, SIX5, NOC2L, ASCL2, NEUROG2, NEUROG1, JAG1, TOP2B, YAF2, STAG1, MLXIPL, ORC5, ORC2, ALYREF, EPRS, SRXN1, MTF1, EEF1G, LMO2, RFX1, SREBF1, CDK6, MBD2, ZNF777, LIN54, HES4, HMX1	nuclear origin of replication recognition complex [CC], sequence-specific DNA binding transcription factor activity [MF], nucleoplasm [CC], nucleic acid binding [MF], DNA binding [MF], DNA replication origin binding [MF], positive regulation of transcription, DNA-dependent [BP], transcription regulatory region DNA binding [MF], protein dimerization activity [MF], DNA topological change [BP], positive regulation of transcription from RNA polymerase II promoter [BP], chromatin binding [MF], regulation of erythrocyte differentiation [BP], regulation of transcription from RNA polymerase II promoter [BP], origin recognition complex [CC], negative regulation of cell aging [BP], E-box binding [MF], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP]
CG_adsipsc_promoter_n_RM_12_11_10	2	0.4	1.78E-04	PMVK	phosphomevalonate kinase activity [MF]
CG_adsipsc_promoter_n_RM_16_17_8	4	0.4	2.99E-04	TCF3, VDR	vitamin D response element binding [MF]
CG_adsipsc_promoter_n_RM_12_190_6	4	0.6	4.05E-04	TAL1, POU3F1, EYA3, LMO2	E-box binding [MF], transcription factor complex [CC], embryonic hemopoiesis [BP], RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription [MF]
CG_adsipsc_promoter_n_RM_16_32_11	6	0.8	4.64E-04	PABPC1, BCL11A, SFMBT1, EZH2, ECE1, CBX4, CEBPA, KLF10, NUP62, TWIST1, TFPT, RORC, WHSC1L1, MED16, ELL2, EBF3, ARGLU1, SHANK1, TCF15, TFAP2A, BCL6, CACNB1, JHDM1D	eyelid development in camera-type eye [BP], synapse maturation [BP], embryonic camera-type eye formation [BP], sarcoplasmic reticulum [CC], positive regulation of dendritic spine development [BP], ear development [BP], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], gene expression [BP], RNA metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_313_19	5	0.8	2.89E-04	YIF1A, CLINT1	clathrin binding [MF], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_n_RM_14_261_4	2	0.2	2.45E-04	GCH1, GALNS, FOXS1, PDLIM3, PLAA	embryonic heart tube development [BP], phospholipase A2 activator activity [MF], GTP cyclohydrolase I activity [MF], heart development [BP], N-acetylgalactosamine-6-sulfatase activity [MF]
CG_adsipsc_promoter_n_RM_12_373_11	2	0.2	4.04E-04	AXIN1, GSK3A	beta-catenin destruction complex [CC]
CG_adsipsc_promoter_n_RM_12_454_15	6	1.0	3.83E-04	HNRNPA2B1, OBFC1	single-stranded telomeric DNA binding [MF]
CG_adsipsc_promoter_n_RM_16_19_6	2	0.2	2.30E-04	LHX6, CEBPA	cell maturation [BP]
CG_adsipsc_promoter_n_RM_14_95_5	1	0.2	3.90E-04	SALL1	inductive cell-cell signaling [BP], histone deacetylation [BP]
CG_adsipsc_promoter_n_RM_16_3_9	9	1.0	4.10E-04	TRIP12, PTK2, HECTD1	protein ubiquitination involved in ubiquitin-dependent protein catabolic process [BP], establishment of nucleus localization [BP]
CG_adsipsc_promoter_n_RM_14_267_6	1	0.2	4.16E-04	RUNX1, SATB1, WNT10B	nuclear heterochromatin [CC], hematopoietic stem cell proliferation [BP]
CG_adsipsc_promoter_n_RM_14_308_7	6	0.8	3.42E-04	RASGEF1C, ARAP2, RHOC	regulation of small GTPase mediated signal transduction [BP]
CG_adsipsc_promoter_n_RM_12_40_19	7	1.0	3.11E-04	EAPP, RHEB, SMAD9, DAB2, RRAGD	positive regulation of transcription elongation from RNA polymerase II promoter [BP], cellular response to organic cyclic compound [BP], positive regulation of TOR signaling cascade [BP]
CG_adsipsc_promoter_n_RM_12_22_21	5	1.0	2.87E-04	TONSL, TRADD, PURB, WASL, NACC2, BCL2, IRX3, RIPK4, GCNT4	metanephros development [BP], death domain binding [MF], cellular protein complex localization [BP], tissue morphogenesis [BP], morphogenesis of an epithelium [BP], DNA replication factor A complex [CC]
CG_adsipsc_promoter_n_RM_14_65_9	1	0.2	2.66E-04	EXT1, FASN	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], oleoyl-[acyl-carrier-protein] hydrolase activity [MF], myristoyl-[acyl-carrier-protein] hydrolase activity [MF], [acyl-carrier-protein] S-malonyltransferase activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], 3-oxoacyl-[acyl-carrier-protein] synthase activity [MF], palmitoyl-[acyl-carrier-protein] hydrolase activity [MF], N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [MF], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], heparan sulfate N-acetylglucosaminyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_50_20	2	0.4	2.16E-04	TESC, PTCH1	protein targeting to plasma membrane [BP]
CG_adsipsc_promoter_n_RM_14_310_22	5	0.6	4.81E-04	RHOA, SPIRE1, MYL3, COBL	cleavage furrow formation [BP], actin monomer binding [MF]
CG_adsipsc_promoter_n_RM_12_478_9	8	1.0	3.25E-04	LEF1, CHD8	armadillo repeat domain binding [MF]
CG_adsipsc_promoter_n_RM_14_361_8	9	1.0	3.81E-04	EDN2, NADKD1, IL6ST	interleukin-11 binding [MF], macrophage chemotaxis [BP], NAD metabolic process [BP], negative regulation of interleukin-6-mediated signaling pathway [BP], interleukin-11 receptor activity [MF], hormonal regulation of the force of heart contraction [BP], ciliary neurotrophic factor receptor complex [CC], interleukin-27-mediated signaling pathway [BP]
CG_adsipsc_promoter_n_RM_14_343_11	7	1.0	3.80E-04	APBB2, PSMD12, EZH2, RBP4, ZNF423, UCN, NDRG2, TLR9, SHANK1, HEY1, APBB1	S phase of mitotic cell cycle [BP], negative regulation of S phase of mitotic cell cycle [BP], associative learning [BP], heart trabecula formation [BP], maintenance of gastrointestinal epithelium [BP], cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_126_15	2	0.2	4.07E-04	TPMT, ID3, NOTCH1, MFSD10, LUZP1, AKR1B1, TNNT2	thiopurine S-methyltransferase activity [MF], negative regulation of osteoblast differentiation [BP], glyceraldehyde oxidoreductase activity [MF], ventricular cardiac muscle tissue morphogenesis [BP], cardiac atrium morphogenesis [BP], ventricular septum development [BP], tetracycline transporter activity [MF], heart development [BP]
CG_adsipsc_promoter_n_RM_12_222_27	8	1.0	3.83E-04	LPHN1, SLIT1, STAT5B, CA10, SLC23A1, KLK8, PAX6, SALL1, RELN, NPTX1, ADA, NKX2-2, ABCB6, FGFR2, PAFAH1B3, MDGA1, JAK3	response to interleukin-2 [BP], digestive tract development [BP], spinal cord development [BP], positive regulation of synapse maturation [BP], negative regulation of thymocyte apoptotic process [BP], regulation of synapse organization [BP], brain development [BP], embryonic digestive tract development [BP], central nervous system development [BP], lacrimal gland development [BP], oligodendrocyte cell fate specification [BP], spinal cord patterning [BP]
CG_adsipsc_promoter_n_RM_12_353_12	4	0.8	3.93E-04	PGGT1B, TGDS	dTDP-glucose 4,6-dehydratase activity [MF], CAAX-protein geranylgeranyltransferase complex [CC]
CG_adsipsc_promoter_n_RM_16_11_3	2	0.2	1.68E-04	SDC3, STX1A	cytoskeletal protein binding [MF], myosin head/neck binding [MF]
CG_adsipsc_promoter_n_RM_14_42_12	3	0.4	3.28E-04	SALL1, SCRIB	neural tube closure [BP]
CG_adsipsc_promoter_n_RM_12_120_9	4	0.6	3.07E-04	HOMER2, DPYSL3, RAB27A	chemical homeostasis within a tissue [BP], exocytic vesicle [CC]
CG_adsipsc_promoter_n_RM_12_109_16	3	0.6	3.62E-04	CDH2, JUP	alpha-catenin binding [MF], fascia adherens [CC], catenin complex [CC]
CG_adsipsc_promoter_n_RM_12_17_10	5	1.0	1.77E-04	CEBPA, STAR, GFI1, IRS1, SLC2A1, SF1, STRA13, SMAD2, ITPR2, MESP1, TOP2B, HDAC4, IGF2	energy reserve metabolic process [BP], positive regulation of glycogen biosynthetic process [BP], generation of precursor metabolites and energy [BP], enzyme binding [MF], insulin-like growth factor receptor binding [MF], activating transcription factor binding [MF], insulin secretion [BP], lateral mesoderm development [BP], positive regulation of insulin receptor signaling pathway [BP], regulation of steroid biosynthetic process [BP], cellular response to organic cyclic compound [BP], negative regulation of cell fate specification [BP], resolution of meiotic recombination intermediates [BP]
CG_adsipsc_promoter_n_RM_14_324_7	2	0.2	2.92E-04	MSRB1, INTS1	methionine-R-sulfoxide reductase activity [MF], U2 snRNA 3'-end processing [BP]
CG_adsipsc_promoter_n_RM_12_86_10	2	0.4	2.34E-04	CD24, PYCARD	positive regulation of activated T cell proliferation [BP]
CG_adsipsc_promoter_n_RM_12_61_8	3	0.6	3.28E-04	NMU	neuromedin U receptor binding [MF]
CG_adsipsc_promoter_n_RM_12_35_9	4	0.8	2.02E-04	PRPF8, SNRNP40, TJP1, TEAD3	hippo signaling cascade [BP], U5 snRNP [CC]
CG_adsipsc_promoter_n_RM_12_201_11	3	0.6	4.70E-04	ICMT, PCYT2	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], ethanolamine-phosphate cytidylyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_77_7	5	0.4	4.68E-04	MEX3D, MGAT1	mRNA localization resulting in posttranscriptional regulation of gene expression [BP], alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_adsipsc_promoter_n_RM_12_75_18	4	0.8	2.68E-04	GATM, MGEA5, PCSK6, BCL2, HYAL2	hyalurononglucosaminidase activity [MF], regulation of glycoprotein biosynthetic process [BP], zygotic determination of anterior/posterior axis, embryo [BP], cellular nitrogen compound metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_215_17	5	0.8	4.72E-04	RPS6KA5, SLC27A5	histone H2A-S1 phosphorylation [BP], cholate-CoA ligase activity [MF]
CG_adsipsc_promoter_n_RM_12_343_18	6	1.0	2.88E-04	CASP3, FGF3	semicircular canal morphogenesis [BP], cell fate commitment [BP]
CG_adsipsc_promoter_n_RM_14_249_11	3	0.4	2.51E-04	PCYT2, RELN, NKX3-1, SLC16A1	MADS box domain binding [MF], mevalonate transport [BP], positive regulation of androgen secretion [BP], positive regulation of phosphatidylinositol 3-kinase cascade [BP], ethanolamine-phosphate cytidylyltransferase activity [MF], positive regulation of long-term synaptic potentiation [BP], mevalonate transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_12_181_12	4	0.6	3.55E-04	RYK, TRABD2A	Wnt-protein binding [MF]
CG_adsipsc_promoter_n_RM_14_301_5	4	0.8	2.29E-04	CDK6, NACC2	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], cell dedifferentiation [BP]
CG_adsipsc_promoter_n_RM_12_316_15	3	0.4	4.19E-04	ANKLE2, TTLL1, TBX3	atrioventricular bundle cell differentiation [BP], sinoatrial node cell development [BP], tubulin-glutamic acid ligase activity [MF], mitotic nuclear envelope reassembly [BP]
CG_adsipsc_promoter_n_RM_12_143_11	4	0.6	2.77E-04	AGAP2, ARAP2, ACAP3, SLC27A5	regulation of ARF GTPase activity [BP], ARF GTPase activator activity [MF], plasma membrane long-chain fatty acid transport [BP]
CG_adsipsc_promoter_n_RM_12_122_7	3	0.6	2.37E-04	HOOK2	early endosome to late endosome transport [BP]
CG_adsipsc_promoter_n_RM_14_169_7	7	1.0	4.12E-04	PLXND1, FOXP3, ITGB1, TP53BP2, GAS1	axon guidance [BP], NF-kappaB binding [MF]
CG_adsipsc_promoter_n_RM_12_311_17	3	0.6	2.52E-04	PRKDC, AGMAT, GIPC1, LEPRE1, PHYH, ISOC2	protein destabilization [BP], regulation of protein stability [BP], L-ascorbic acid binding [MF], polyamine metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_258_15	4	0.6	3.71E-04	HYAL2	receptor signaling protein tyrosine kinase inhibitor activity [MF], hyaluronoglucuronidase activity [MF]
CG_adsipsc_promoter_n_RM_12_245_8	3	0.6	3.80E-04	SIAH1, BBC3	positive regulation of intrinsic apoptotic signaling pathway [BP]
CG_adsipsc_promoter_n_RM_14_160_7	7	1.0	4.03E-04	ATF2, ICMT	cAMP response element binding protein binding [MF]
CG_adsipsc_promoter_n_RM_12_229_11	5	0.8	3.96E-04	GNB1, CD34, PHLPP2	photoreceptor outer segment membrane [CC], positive regulation of transforming growth factor beta production [BP]
CG_adsipsc_promoter_n_RM_14_368_10	6	0.8	4.02E-04	PNKP, MCMBP	DNA-dependent DNA replication [BP]
CG_adsipsc_promoter_n_RM_16_42_4	1	0.2	6.19E-04	NPPA, CRH	peptide hormone receptor binding [MF], ferulate metabolic process [BP], corticotropin-releasing hormone activity [MF]
CG_adsipsc_promoter_n_RM_12_382_19	6	1.0	3.33E-04	DNMT1	centromeric heterochromatin [CC]
CG_adsipsc_promoter_n_RM_12_441_16	4	0.6	3.64E-04	GOT1, DGAT1	fatty acid homeostasis [BP]
CG_adsipsc_promoter_n_RM_16_15_10	4	0.4	1.51E-04	GCLC, PNKP, ERCC1	nucleotide-excision repair, DNA damage removal [BP], response to oxidative stress [BP]
CG_adsipsc_promoter_n_RM_18_4_4	4	0.4	5.09E-04	NOTCH2, GALNT3, XYLT1	Golgi membrane [CC], Golgi apparatus [CC], protein xylosyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_12_378_26	3	0.6	2.70E-04	CCBE1, GDF2, NOTCH1, SLC12A6, NKX3-1, SOX18	angiogenesis [BP], vasculogenesis [BP], vasculature development [BP], regulation of epithelial cell proliferation involved in prostate gland development [BP], venous blood vessel morphogenesis [BP], endocardium morphogenesis [BP], blood vessel morphogenesis [BP], lymphangiogenesis [BP], endocardium development [BP], endocardial cell differentiation [BP], branching morphogenesis of an epithelial tube [BP]
CG_adsipsc_promoter_n_RM_12_196_5	4	0.8	2.46E-04	NOTCH1	venous endothelial cell differentiation [BP], regulation of extracellular matrix assembly [BP], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP]
CG_adsipsc_promoter_n_RM_12_203_29	9	1.0	2.75E-04	MYOF, MYH10	plasma membrane repair [BP]
CG_adsipsc_promoter_n_RM_12_241_9	4	0.6	3.11E-04	SERP1, HYAL2	multicellular organismal aging [BP]
CG_adsipsc_promoter_n_RM_12_326_17	4	0.6	3.06E-04	CDC26, DEDD2, NR6A1, AHCTF1, REV1	nucleoplasm [CC], positive regulation of extrinsic apoptotic signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_393_20	6	0.8	2.47E-04	GALNS, ACP2, SDC3	lysosomal lumen [CC]
CG_adsipsc_promoter_n_RM_12_42_14	4	0.8	2.56E-04	NR4A2, NPTN, HOXA1, FGF8, GAS1	outer ear morphogenesis [BP], type 1 fibroblast growth factor receptor binding [MF], dopaminergic neuron differentiation [BP]
CG_adsipsc_promoter_n_RM_14_307_6	2	0.2	1.91E-04	ICMT, EXOSC10	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], nuclear retention of unspliced pre-mRNA at the site of transcription [BP]
CG_adsipsc_promoter_n_RM_14_389_4	1	0.2	2.90E-04	AES, SMAD7, NFKBIA, BTG1, NR2F6, RBBP7, FLII, PTCH1, ZC3H8	negative regulation of sequence-specific DNA binding transcription factor activity [BP], positive regulation of cholesterol efflux [BP], negative regulation of transcription from RNA polymerase II promoter [BP], regulation of transcription, DNA-dependent [BP], negative regulation of transcription, DNA-dependent [BP], multicellular organismal development [BP]
CG_adsipsc_promoter_n_RM_14_268_4	3	0.4	3.58E-04	LBX1, CAMK2B, DUSP16	MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], inhibitory G-protein coupled receptor phosphorylation [BP], MAPK export from nucleus [BP], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP]
CG_adsipsc_promoter_n_RM_16_33_2	1	0.2	3.48E-04	MAP4K1	MAP kinase kinase kinase kinase activity [MF]
CG_adsipsc_promoter_n_RM_12_106_14	3	0.6	2.01E-04	HIBCH, EOMES	mesodermal to mesenchymal transition involved in gastrulation [BP], 3-hydroxyisobutyryl-CoA hydrolase activity [MF]
CG_adsipsc_promoter_n_RM_14_30_6	2	0.2	1.94E-04	ALG3	dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_12_397_14	5	0.8	3.50E-04	CDK6	cell dedifferentiation [BP]
CG_adsipsc_promoter_n_RM_12_459_15	6	1.0	2.74E-04	CTSH, SMARCC1, ZFR, ENTPD8, CTSL2, TOP2B, DPP7, DNPEP	WINAC complex [CC], aminopeptidase activity [MF], nucleoside diphosphate biosynthetic process [BP], chromosome [CC], kininogen binding [MF], apoptotic protease activator activity [MF]
CG_adsipsc_promoter_n_RM_14_341_2	1	0.2	2.04E-04	ATPBD4, SIT1	diphthine-ammonia ligase activity [MF], regulation of T cell activation [BP]
CG_adsipsc_promoter_n_RM_14_264_6	3	0.2	4.50E-04	ERCC2, NCBP2, PAX3, TCEA1, PDGFRB	metanephric mesenchyme development [BP], positive regulation of viral transcription [BP], transcription from RNA polymerase II promoter [BP], transcription elongation from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_23_22	5	0.6	2.77E-04	KLK14, PDE6G	positive regulation of G-protein coupled receptor protein signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_450_11	5	1.0	3.32E-04	FZD8, SLC4A11	phosphoenolpyruvate-dependent sugar phosphotransferase system [BP], positive regulation of JUN kinase activity [BP], borate transmembrane transporter activity [MF], borate transport [BP], fluid transport [BP], borate transmembrane transport [BP]
CG_adsipsc_promoter_n_RM_16_37_4	3	0.6	6.83E-04	YARS2, RENBP	N-acylglucosamine 2-epimerase activity [MF], N-acetylmannosamine metabolic process [BP], tyrosine binding [MF], tyrosine-tRNA ligase activity [MF], mitochondrial tyrosyl-tRNA aminoacylation [BP]
CG_adsipsc_promoter_n_RM_12_206_26	5	0.8	2.90E-04	TNIP1, CDX2, ALYREF, ATXN3, STAT5B, DEK, JAK3, POLR2L, PBX4, JOSD2, USP34, ETS1, SIN3A, FOXJ1	activation of innate immune response [BP], response to interleukin-2 [BP], ubiquitin-specific protease activity [MF], transcription from RNA polymerase II promoter [BP], activation of Rho GTPase activity [BP]
CG_adsipsc_promoter_n_RM_12_149_6	3	0.6	4.57E-04	TMLHE, SLC26A6, ICMT, POMGNT1	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], C-terminal protein methylation [BP], beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [MF], trimethyllysine dioxygenase activity [MF], formate transmembrane transporter activity [MF], protein C-terminal carboxyl O-methyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_34_7	2	0.2	2.68E-04	GLO1, ASPM	negative regulation of asymmetric cell division [BP], lactoylglutathione lyase activity [MF]
CG_adsipsc_promoter_n_RM_14_53_7	2	0.2	2.09E-04	AXIN2, SPG20, ATP5L2	regulation of mitochondrial membrane potential [BP], mRNA stabilization [BP], hydrogen ion transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_12_335_10	2	0.4	1.96E-04	BBC3, ZC3H8	positive regulation of thymocyte apoptotic process [BP]
CG_adsipsc_promoter_n_RM_14_302_10	3	0.2	3.18E-04	SLC19A1, HDDC3	guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], methotrexate transport [BP], methotrexate transporter activity [MF]
CG_adsipsc_promoter_n_RM_12_273_14	2	0.4	2.62E-04	USP22, GNPTAB	UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [MF], SAGA-type complex [CC]
CG_adsipsc_promoter_n_RM_14_283_8	5	0.4	3.10E-04	GSC, BOLL, PABPC1, TBX20	RNA polymerase II transcription factor binding [MF], translation activator activity [MF]
CG_adsipsc_promoter_n_RM_12_80_16	3	0.6	3.23E-04	TBL1XR1, POU4F1, CNTFR, WNT7A, WNT7B, SOX18	lens fiber cell development [BP], suckling behavior [BP], cellular metabolic process [BP], canonical Wnt receptor signaling pathway [BP], central nervous system vasculogenesis [BP], establishment of endothelial barrier [BP]
CG_adsipsc_promoter_n_RM_16_29_21	6	0.8	4.16E-04	FGFR2, NCOR1, HIRA, CDK6, TWIST1	negative regulation of cellular senescence [BP], regulation of osteoblast differentiation [BP], osteoblast differentiation [BP], cranial suture morphogenesis [BP], ossification [BP], negative regulation of phosphatidylinositol 3-kinase cascade [BP]
CG_adsipsc_promoter_n_RM_12_100_6	3	0.4	3.18E-04	IRS2, GSK3B, PDGFRB	phosphatidylinositol-mediated signaling [BP], phosphatidylinositol 3-kinase binding [MF]
CG_adsipsc_promoter_n_RM_12_77_11	7	1.0	3.81E-04	ELOVL2, ELOVL4	long-chain fatty-acyl-CoA biosynthetic process [BP], very long-chain fatty acid biosynthetic process [BP]
CG_adsipsc_promoter_n_RM_12_90_8	2	0.2	2.83E-04	PTK2, PRKACA, AXIN2, SIAH1, PDZRN3	central nervous system neuron axonogenesis [BP], beta-catenin destruction complex [CC], regulation of osteoblast differentiation [BP], neuromuscular junction [CC]
CG_adsipsc_promoter_n_RM_12_287_8	8	0.8	3.74E-04	DLL1, DVL2	segment specification [BP], loop of Henle development [BP]
CG_adsipsc_promoter_n_RM_14_57_9	6	0.6	2.91E-04	DENND1A, IFNLR1, EEA1	synaptic vesicle endocytosis [BP], regulation of defense response to virus by host [BP], early endosome to late endosome transport [BP]
CG_adsipsc_promoter_n_RM_12_469_16	5	1.0	3.36E-04	ZNF354A, COL11A2, CBX8, FZD4, CBX4, CLIC5	sensory perception of sound [BP], PRC1 complex [CC]
CG_adsipsc_promoter_n_RM_14_76_11	2	0.2	3.50E-04	DLL1	loop of Henle development [BP]
CG_adsipsc_promoter_n_RM_12_470_7	4	0.8	2.26E-04	FGF20	regulation of cardiac muscle cell proliferation [BP]
CG_adsipsc_promoter_n_RM_20_2_2	1	0.2	2.56E-04	ABCA2, TPST2, PRODH	proline dehydrogenase activity [MF], peptidyl-tyrosine sulfation [BP], regulation of intracellular cholesterol transport [BP], protein-tyrosine sulfotransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_244_4	3	0.4	3.30E-04	AZIN1, SPOCK1, CNN3, SRCIN1	postsynaptic density [CC], negative regulation of catalytic activity [BP]
CG_adsipsc_promoter_n_RM_12_115_12	5	0.6	3.30E-04	SOX10, CNTFR, SH2D2A, T, NACC2, FGFR2, ASTL	positive regulation of cell proliferation [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF], cell proliferation [BP], RNA polymerase II distal enhancer sequence-specific DNA binding [MF], fertilization [BP]
CG_adsipsc_promoter_n_RM_12_92_7	3	0.4	2.30E-04	WHSC1L1	chromosome [CC]
CG_adsipsc_promoter_n_RM_12_384_15	7	1.0	2.54E-04	NMRK1, UCKL1, NKX2-2	uridine kinase activity [MF], digestive tract development [BP]
CG_adsipsc_promoter_n_RM_14_55_9	4	0.6	3.78E-04	RBP4, TLR9	maintenance of gastrointestinal epithelium [BP]
CG_adsipsc_promoter_n_RM_12_104_8	2	0.4	2.96E-04	MAD1L1, AKT1, PPAT, PRPF19, SEPT12, GAREM	cellular response to epidermal growth factor stimulus [BP], purine nucleobase biosynthetic process [BP], spindle [CC]
CG_adsipsc_promoter_n_RM_12_73_21	4	0.6	2.76E-04	CTBP1	regulation of transcription by chromatin organization [BP]
CG_adsipsc_promoter_n_RM_12_280_17	8	1.0	2.71E-04	TLE3, EEF1A2, PDS5A, CYCS, TTF1, POLG, FBXO5, USP28, PAXBP1, SOX18, GCNT4, HACE1, FEZF1, CEBPD, CHD8, AHNAK, AFF4, SIX1, CBFA2T3, ZIC5, MLF2, NEUROG1, C2CD2, GABPB1, VRK3, ALYREF, ZFP36L2, SLFN11, VCP, ESX1, ZNF821, SALL1, PHLPP2, IMPDH1, LEF1, SSBP2, ZNF3, RPS6KA2, RAB11FIP5, UCKL1, PKD1, H2AFX, STAT5B, PURB, HES6, ZBTB46, ZBTB21, IL15RA, CINP, GTF2A1, RECQL4	nucleus [CC], mitotic metaphase [BP], sequence-specific DNA binding transcription factor activity [MF], positive regulation of natural killer cell differentiation [BP], kidney morphogenesis [BP], DNA binding [MF], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_n_RM_14_111_12	5	0.6	2.54E-04	NANOS2, SAMD1, JAK1, CENPV, YBX2, NOSIP	cytoplasm [CC]
CG_adsipsc_promoter_n_RM_12_447_10	5	0.8	2.10E-04	OCA2	arsenite transport [BP], tyrosine transport [BP], L-tyrosine transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_20_4_2	1	0.2	7.46E-04	HIST3H2A, HIST1H1B, H2AFX	nucleosome assembly [BP], nucleosome [CC], nuclear chromatin [CC]
CG_adsipsc_promoter_n_RM_14_365_6	3	0.2	2.69E-04	SULF2, RPS4X, MLL2, BAD, PRKACA, NACC2, RHOG, PDGFB	response to estrogen stimulus [BP], intrinsic apoptotic signaling pathway [BP], fibroblast growth factor receptor signaling pathway [BP], glomerular filtration [BP], positive regulation of cell proliferation [BP], cellular response to growth factor stimulus [BP]
CG_adsipsc_promoter_n_RM_14_12_2	2	0.2	5.40E-04	RELA, ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], acetaldehyde metabolic process [BP], inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_adsipsc_promoter_n_RM_12_275_11	6	0.8	3.96E-04	BCOR, DHCR7, AKR1B1	glyceraldehyde oxidoreductase activity [MF], 7-dehydrocholesterol reductase activity [MF], negative regulation of histone H3-K36 methylation [BP]
CG_adsipsc_promoter_n_RM_12_226_8	4	0.6	2.71E-04	STRA13, FANCG	Fanconi anaemia nuclear complex [CC]
CG_adsipsc_promoter_n_RM_16_38_3	5	1.0	3.21E-04	TRPM7, TBX3	blood vessel development [BP], atrioventricular bundle cell differentiation [BP], calcium-dependent cell-matrix adhesion [BP], sinoatrial node cell development [BP]
CG_adsipsc_promoter_n_RM_12_91_10	5	0.8	2.80E-04	NOTCH1, FOXA1	neural tube development [BP], secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [BP], branching morphogenesis of an epithelial tube [BP], prostate gland epithelium morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_38_14	2	0.4	1.09E-04	SLBP	regulation of S phase [BP]
CG_adsipsc_promoter_n_RM_14_363_5	3	0.4	3.92E-04	ARHGDIA, RTN4R	negative regulation of axonogenesis [BP]
CG_adsipsc_promoter_n_RM_14_342_15	4	0.6	3.39E-04	NACC2, WASL, EOMES	trophectodermal cell differentiation [BP], cellular protein complex localization [BP]
CG_adsipsc_promoter_n_RM_12_208_16	6	1.0	2.99E-04	DLG4, EIF2AK3, FOXA1, PAX6, NKX2-2, PARD3	neuron fate commitment [BP], neuron fate specification [BP], oligodendrocyte cell fate specification [BP], protein phosphatase binding [MF]
CG_adsipsc_promoter_n_RM_14_59_4	2	0.4	4.57E-04	RBBP7, AXIN2, GATM, PDGFA	glycine amidinotransferase activity [MF], cellular heat acclimation [BP], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP], regulation of chondrocyte development [BP]
CG_adsipsc_promoter_n_RM_14_92_6	2	0.2	2.47E-04	CBX4, TOB1, YAF2, ALG9	transcription corepressor activity [MF], dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF], dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_12_1_22	6	0.8	3.59E-04	CHD4, APPL2	NuRD complex [CC]
CG_adsipsc_promoter_n_RM_12_439_9	2	0.2	2.38E-04	ACSL4	arachidonate-CoA ligase activity [MF], negative regulation of prostaglandin secretion [BP]
CG_adsipsc_promoter_n_RM_14_105_9	4	0.4	3.16E-04	UBE2N, ERO1L	positive regulation of histone modification [BP], oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [MF]
CG_adsipsc_promoter_n_RM_14_348_5	5	0.8	3.90E-04	NCOA6, CFL1, HEY1, AKT1	labyrinthine layer blood vessel development [BP], neural fold formation [BP]
CG_adsipsc_promoter_n_RM_14_217_13	5	0.8	3.43E-04	MYL3	regulation of the force of heart contraction [BP]
CG_adsipsc_promoter_n_RM_12_126_11	2	0.2	4.54E-04	WT1, NR3C1, RRP8, GLYR1	methylated histone residue binding [MF], adrenal gland development [BP]
CG_adsipsc_promoter_n_RM_12_53_6	3	0.6	3.10E-04	ANKRD27, CD8B, KIAA0226	early endosome [CC]
CG_adsipsc_promoter_n_RM_14_186_6	3	0.2	1.75E-04	DTYMK, SRD5A2, TSHZ3	nucleoside monophosphate phosphorylation [BP], sterol 5-alpha reductase activity [MF], nucleoside phosphate kinase activity [MF], ureteric peristalsis [BP]
CG_adsipsc_promoter_n_RM_14_39_6	2	0.2	3.12E-04	HMGB1, TRPT1, SGK1, GATM	tRNA 2'-phosphotransferase activity [MF], glycine amidinotransferase activity [MF], positive regulation of transporter activity [BP], negative regulation of apoptotic cell clearance [BP]
CG_adsipsc_promoter_n_RM_14_215_10	2	0.2	3.45E-04	BAP1, EXTL2	heparan sulfate proteoglycan biosynthetic process [BP], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_n_RM_12_171_16	4	0.6	2.15E-04	VPS37C, DLG4, RELN, AP1M2	protein localization to synapse [BP], positive regulation of excitatory postsynaptic membrane potential [BP], cellular membrane organization [BP], regulation of N-methyl-D-aspartate selective glutamate receptor activity [BP], receptor localization to synapse [BP]
CG_adsipsc_promoter_n_RM_14_201_9	2	0.2	3.12E-04	P4HB, TXN2	glycerol ether metabolic process [BP], protein disulfide oxidoreductase activity [MF]
CG_adsipsc_promoter_n_RM_12_428_11	3	0.4	2.46E-04	BVES, NOC2L, EPHA2, IRS2, ZFP36L1, INSRR, PYCARD, HEG1	phosphatidylinositol 3-kinase binding [MF], vasculogenesis [BP], negative regulation of B cell apoptotic process [BP], regulation of Rac GTPase activity [BP]
CG_adsipsc_promoter_n_RM_12_249_12	3	0.6	2.15E-04	GIPC1, AXIN1, FAF1	proteasomal ubiquitin-dependent protein catabolic process [BP], positive regulation of transforming growth factor beta receptor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_14_6_2	1	0.2	3.04E-04	RANGAP1, HEG1	lymph circulation [BP], positive regulation of Ran GTPase activity [BP], Ran GTPase activator activity [MF]
CG_adsipsc_promoter_n_RM_12_207_9	5	0.8	2.33E-04	CARD10	receptor signaling complex scaffold activity [MF]
CG_adsipsc_promoter_n_RM_12_183_21	4	0.6	2.79E-04	NHLRC1, SMG6, SAPCD2, RPS27L, ERRFI1, MAMSTR, GNB2L1, MEFV, DEPDC1, DUSP18, PITRM1, CIZ1, NECAB3, TRIM7, CTNND2, IRF2BP2	cysteine-type endopeptidase activator activity involved in apoptotic process [MF], positive regulation of cysteine-type endopeptidase activity [BP], enzyme activator activity [MF], negative regulation of protein tyrosine kinase activity [BP], regulation of establishment of protein localization to plasma membrane [BP], nucleus [CC]
CG_adsipsc_promoter_n_RM_12_168_12	7	1.0	1.66E-04	CIZ1	maintenance of nucleus location [BP]
CG_adsipsc_promoter_n_RM_14_18_8	3	0.2	2.40E-04	PLEKHJ1, CADPS2, AKT1, RUNX1, DUSP16, WNT7B, TOP2A, LHX3	MAPK export from nucleus [BP], viral integration complex [CC], positive regulation of retroviral genome replication [BP], outer medullary collecting duct development [BP], establishment or maintenance of polarity of embryonic epithelium [BP], MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], glycogen cell differentiation involved in embryonic placenta development [BP], DNA topoisomerase complex (ATP-hydrolyzing) [CC], positive regulation of progesterone secretion [BP], embryonic organ development [BP], placenta development [BP], phospholipid binding [MF], protein kinase C binding [MF]
CG_adsipsc_promoter_n_RM_14_140_11	2	0.2	3.41E-04	OAT	ornithine-oxo-acid transaminase activity [MF]
CG_adsipsc_promoter_n_RM_12_433_11	2	0.4	3.45E-04	ABCB6	heme-transporting ATPase activity [MF]
CG_adsipsc_promoter_n_RM_12_205_9	5	0.6	1.66E-04	FANCA, FANCC	Fanconi anaemia nuclear complex [CC]
CG_adsipsc_promoter_n_RM_20_14_1	1	0.2	5.89E-04	SLC23A2, TGM2	L-ascorbate:sodium symporter activity [MF], sodium-dependent L-ascorbate transmembrane transporter activity [MF], L-ascorbic acid transport [BP], transepithelial L-ascorbic acid transport [BP], isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [BP], L-ascorbic acid transporter activity [MF], molecular hydrogen transport [BP], sodium-dependent multivitamin transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_12_445_19	5	0.8	2.99E-04	TGFBR3, MDC1, MACROD1, SNX5, HMGB1, DNER, SH3BP5, RIPK3, AKT3, HPS1, PNMA1, MAP3K5, CRYGD, THBD, SIX5, ZZZ3, PPM1G, KANSL1, PLXNB1, STAT3, PREX1, CAMK1, CYS1, ATP5A1, DGKI, CBFA2T3, GCC1, FAF1, ARHGAP21, ITPKB, PPP1R12A, MAGI1, ATG5, NACC2, RPGRIP1L, JAG1, RAB14, GEM, GRIN2A, EDF1, BEND7, DNMT3A, DOK4, PARP4, FIBCD1, XPO1, ARHGAP4, ALYREF, FOXS1, ANXA11, APLN, TCP11, TP53BP2, CDKN2B, LOXL4, PLAA, ANAPC2, TUBB2B, FAM154A, IRF1, SOS2, ADCY3, KIAA0319L, LRP8, FBXL5, KIF13B, YY1AP1, GDNF, ALKBH8, GFRA2, STC2, DEDD2, DKK4, SNX3	protein binding [MF], cell surface receptor signaling pathway [BP], signal transduction [BP], cell communication [BP], multicellular organismal development [BP], nervous system development [BP]
CG_adsipsc_promoter_n_RM_14_205_4	2	0.2	1.98E-04	NEUROG2, PER1, UCK1	E-box binding [MF], pyrimidine nucleobase metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_462_5	2	0.2	2.00E-04	SNCA, HAND2, CCK, GSK3B, TNFRSF10A	negative regulation of norepinephrine uptake [BP], activation of cysteine-type endopeptidase activity involved in apoptotic process [BP], negative regulation of dopamine uptake involved in synaptic transmission [BP], protein phosphorylation [BP], canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process [BP], tau protein binding [MF], inclusion body [CC], negative regulation of thrombin receptor signaling pathway [BP], terminal bouton [CC], positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [BP], regulation of neuronal synaptic plasticity [BP]
CG_adsipsc_promoter_n_RM_14_222_3	2	0.2	4.11E-04	CPLX1, PIP5K1C	synaptic vesicle exocytosis [BP]
CG_adsipsc_promoter_n_RM_12_297_10	3	0.6	4.53E-04	TRPT1, DEDD2, RBMS1	tRNA 2'-phosphotransferase activity [MF], RNA processing [BP]
CG_adsipsc_promoter_n_RM_14_184_11	2	0.2	3.00E-04	JAG1, CARD9	response to muramyl dipeptide [BP]
CG_adsipsc_promoter_n_RM_18_1_3	4	0.4	2.85E-04	ZIC5, TAF11, REV3L, ZNF18, RPS2, LIN54, POLR2I, ZDHHC1	DNA binding [MF], viral transcription [BP]
CG_adsipsc_promoter_n_RM_14_189_7	3	0.2	2.91E-04	HSPG2	cartilage development involved in endochondral bone morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_45_12	6	1.0	3.76E-04	CEBPA, LRRFIP2, DMRTA2, PAF1, BARX1, SHH, SFRP2	Wnt receptor signaling pathway [BP], cellular response to lithium ion [BP], positive regulation of Wnt receptor signaling pathway [BP], sex differentiation [BP], negative regulation of Wnt receptor signaling pathway [BP], sclerotome development [BP], somite development [BP]
CG_adsipsc_promoter_n_RM_16_4_10	9	1.0	4.21E-04	SMAD7, CPSF7, SOX3, LHX5, NCKAP1, ZNF3, SIX4, NFE2L2, CASK, NKX6-1, ZBTB7A, MECP2, ZNF367, EVX2, CELSR1, FOXN4, SETD3, HEY1, PJA2, GSK3B, FZD8, HOXA1, GFRA2, PID1, KCTD1	apical protein localization [BP], anatomical structure morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], protein kinase A catalytic subunit binding [MF], transcription factor binding [MF], sequence-specific DNA binding transcription factor activity [MF], central nervous system development [BP], generation of neurons [BP], positive regulation of transcription from RNA polymerase II promoter [BP], multicellular organismal development [BP], regulation of transcription from RNA polymerase II promoter [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP], nervous system development [BP]
CG_adsipsc_promoter_n_RM_12_362_16	3	0.6	2.00E-04	SLC23A1	L-ascorbate:sodium symporter activity [MF], dehydroascorbic acid transport [BP], sodium-dependent L-ascorbate transmembrane transporter activity [MF], L-ascorbic acid transport [BP], transepithelial L-ascorbic acid transport [BP], L-ascorbic acid transporter activity [MF]
CG_adsipsc_promoter_n_RM_14_146_7	3	0.2	2.50E-04	POLR2L, RBM28, DHX15, MFSD10	RNA splicing [BP], mRNA processing [BP], tetracycline transport [BP], tetracycline transporter activity [MF]
CG_adsipsc_promoter_n_RM_12_65_8	5	0.8	2.77E-04	BMP4, PRDM14, PDE5A, REEP1, LEF1, WNT11, RPS6KA2	positive regulation of cell death [BP], positive regulation of apoptotic process [BP], cell death [BP], cloacal septation [BP], osteoblast differentiation [BP], germ cell development [BP], mesonephros development [BP], trachea development [BP], negative regulation of mesenchymal cell proliferation [BP], negative regulation of T cell proliferation [BP], heart contraction [BP], negative regulation of striated muscle tissue development [BP], heart development [BP]
CG_adsipsc_promoter_n_RM_12_2_12	4	0.6	2.63E-04	LOXL4, ATP7B, LOX	copper ion binding [MF], protein-lysine 6-oxidase activity [MF]
CG_adsipsc_promoter_n_RM_12_277_12	4	0.6	3.22E-04	MCAT, FASN	fatty acid synthase activity [MF], [acyl-carrier-protein] S-malonyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_15_6	2	0.2	1.46E-04	PAX6, KLHL21, TFCP2L1, BCOR, TLE2	protein ubiquitination [BP], salivary gland development [BP], transcription corepressor activity [MF], ubiquitin-protein ligase activity [MF], negative regulation of histone H3-K36 methylation [BP], commitment of neuronal cell to specific neuron type in forebrain [BP], regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP], pancreatic A cell development [BP], forebrain-midbrain boundary formation [BP]
CG_adsipsc_promoter_n_RM_14_94_5	1	0.2	1.87E-04	RORA, TTF1, EGR2	transcription from RNA polymerase I promoter [BP], rhombomere 3 formation [BP], rhombomere 5 formation [BP], cGMP metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_375_11	5	1.0	3.32E-04	ARL8A, CHMP2A, FEV	neuron fate specification [BP], late endosome membrane [CC]
CG_adsipsc_promoter_n_RM_14_142_6	2	0.2	3.38E-04	PDE10A, HCN1	cAMP binding [MF]
CG_adsipsc_promoter_n_RM_14_266_5	2	0.2	3.55E-04	EDN2	hormonal regulation of the force of heart contraction [BP]
CG_adsipsc_promoter_n_RM_12_320_13	7	1.0	3.60E-04	IFT20, SOX15, EZR, PITX2	microtubule basal body [CC], positive regulation of myoblast proliferation [BP]
CG_adsipsc_promoter_n_RM_12_210_15	3	0.6	2.06E-04	SNX4, EHD1	endocytic recycling [BP]
CG_adsipsc_promoter_n_RM_12_163_11	5	0.8	2.15E-04	TTLL1, CAMK2B, SNW1	inhibitory G-protein coupled receptor phosphorylation [BP], tubulin-glutamic acid ligase activity [MF], SMAD3-SMAD4 protein complex [CC]
CG_adsipsc_promoter_n_RM_14_224_5	2	0.2	3.77E-04	CAMK2B	positive regulation of apoptotic signaling pathway [BP], inhibitory G-protein coupled receptor phosphorylation [BP]
CG_adsipsc_promoter_n_RM_14_11_9	2	0.2	1.93E-04	GATA2, SHARPIN, TOP2A, UBE2N	apoptotic nuclear changes [BP], ubiquitin binding [MF], ventral spinal cord interneuron differentiation [BP]
CG_adsipsc_promoter_n_RM_14_360_2	2	0.4	7.54E-04	HOXB1, SLC17A3, HOXB5, HIST1H1A, HIST1H1B, HOXB3	embryonic skeletal system morphogenesis [BP], DNA binding [MF], urate transmembrane transporter activity [MF], nucleosome assembly [BP], urate transport [BP], anterior/posterior pattern specification [BP], pattern specification process [BP], nucleosome [CC], rhombomere development [BP]
CG_adsipsc_promoter_n_RM_18_9_2	4	0.4	6.62E-04	GALC	galactosylceramide catabolic process [BP], galactosylceramidase activity [MF]
CG_adsipsc_promoter_n_RM_12_47_13	2	0.2	1.96E-04	NOTCH1, OCA2, RBBP7	Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], regulation of extracellular matrix assembly [BP], L-tyrosine transmembrane transporter activity [MF], venous endothelial cell differentiation [BP], arsenite transport [BP], cellular heat acclimation [BP], tyrosine transport [BP]
CG_adsipsc_promoter_n_RM_14_325_4	2	0.4	2.19E-04	SLC38A1, KCNK9, SLC30A1, DHCR7, ACADL	regulation of cholesterol metabolic process [BP], 7-dehydrocholesterol reductase activity [MF], synaptic transmission [BP], negative regulation of zinc ion transmembrane import [BP], carnitine catabolic process [BP]
CG_adsipsc_promoter_n_RM_12_437_12	3	0.6	2.46E-04	BAAT, BAZ1B	bile acid conjugation [BP], vitamin D receptor activator activity [MF], long-chain acyl-CoA hydrolase activity [MF], very long chain acyl-CoA hydrolase activity [MF], DNA replication-dependent nucleosome disassembly [BP], glycine N-choloyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_12_223_9	2	0.4	2.10E-04	BAD, EPHA2, PTRF	notochord cell development [BP], cellular response to chromate [BP], rRNA primary transcript binding [MF], positive regulation of T cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_262_5	1	0.2	1.78E-04	NBN, SLX4	double-strand break repair via homologous recombination [BP], ERCC4-ERCC1 complex [CC], nuclear chromosome, telomeric region [CC], Holliday junction resolvase complex [CC]
CG_adsipsc_promoter_n_RM_12_386_5	4	0.8	4.21E-04	DAPK2, RORA, NKX3-1	autophagic vacuole lumen [CC], ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], MADS box domain binding [MF]
CG_adsipsc_promoter_n_RM_14_102_10	4	0.4	4.48E-04	TOLLIP, ZRANB3, SLC6A9	DNA rewinding [BP], interleukin-18 receptor complex [CC], interleukin-1, Type I receptor binding [MF], glycine:sodium symporter activity [MF]
CG_adsipsc_promoter_n_RM_14_181_7	3	0.2	2.84E-04	GRM8, TPMT	thiopurine S-methyltransferase activity [MF], group III metabotropic glutamate receptor activity [MF]
CG_adsipsc_promoter_n_RM_12_364_14	5	0.8	2.74E-04	HOXA2, OXTR, CNTFR, UCN, WNT7A, FABP3, GBX2	sarcoplasm [CC], negative regulation of gastric acid secretion [BP], suckling behavior [BP], sex differentiation [BP], cerebellum development [BP], rhombomere 2 development [BP]
CG_adsipsc_promoter_n_RM_12_159_10	3	0.6	2.39E-04	JAG1, LRP6, CYBA, ALG3	positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification [BP], morphogenesis of an epithelial sheet [BP], cardiac septum morphogenesis [BP], negative regulation of glomerular filtration by angiotensin [BP], canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [BP], negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [BP], negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [BP], dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [MF], negative regulation of planar cell polarity pathway involved in neural tube closure [BP], coreceptor activity involved in Wnt receptor signaling pathway [MF], endocardial cushion cell development [BP], smooth muscle hypertrophy [BP], negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [BP], negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [BP], negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [BP], negative regulation of fat cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_17_7	3	0.4	3.82E-04	DTNBP1, GPR143, HSP90AA1	melanosome organization [BP], melanosome membrane [CC], melanosome [CC]
CG_adsipsc_promoter_n_RM_14_260_14	2	0.2	4.05E-04	RHOA, ITGA8	cell-matrix adhesion [BP]
CG_adsipsc_promoter_n_RM_14_209_7	2	0.2	3.55E-04	GFRA2, SULF2	glial cell-derived neurotrophic factor receptor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_14_24_13	4	0.4	3.21E-04	TNNT2, NRARP, HEY1, SMAD7	ventricular cardiac muscle tissue morphogenesis [BP], cardiac ventricle morphogenesis [BP], negative regulation of Notch signaling pathway [BP]
CG_adsipsc_promoter_n_RM_14_36_6	4	0.6	3.74E-04	UBE2G1, AXIN2, SLC30A3, GSK3B, QDPR	canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process [BP], beta-catenin destruction complex [CC], 6,7-dihydropteridine reductase activity [MF], zinc transporting ATPase activity [MF], ubiquitin protein ligase binding [MF], positive regulation of GTPase activity [BP], NADH binding [MF], regulation of chondrocyte development [BP]
CG_adsipsc_promoter_n_RM_14_226_14	2	0.2	2.35E-04	BCL2, HYAL2	hematopoietic progenitor cell differentiation [BP], response to UV-B [BP]
CG_adsipsc_promoter_n_RM_12_369_20	5	0.8	3.15E-04	MPHOSPH6, EXOSC6	exosome (RNase complex) [CC]
CG_adsipsc_promoter_n_RM_14_397_9	5	0.6	5.97E-04	GAMT, NGLY1, GSK3B, HOMER1	peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [MF], guanidinoacetate N-methyltransferase activity [MF], canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process [BP], dendritic shaft [CC]
CG_adsipsc_promoter_n_RM_14_371_20	4	0.4	4.44E-04	PDGFRB, KCTD1, BAG1, VCP, CUEDC2, CLOCK, ANKH, ANP32A, INO80, BRD1, TAF12, TAF11, WASL, CBX8, NR1D1, PAXBP1, PELI1, NFE2L2, DEAF1, GCLC, HOXA10, GLI3, ZIC4, ZIC5, FANCA, NEUROG2, NR3C2, GLIS1, ACTL6B, ZBTB5, TCFL5, RP9, MECP2, EVX2, BAZ1A, BARX1, SNAPC4, CENPV, SETD3, MEX3C, BRD3, IRF2, TBL1XR1, MAP2K2, KLLN, H2AFY, DSCR3, SOX3, HOXA6, REV3L, CDK5, HOXA1, OTP, LIN54, XAB2, DSCAML1, GTF2A1, MAD2L2	embryonic skeletal system morphogenesis [BP], gene expression [BP], nucleus [CC], chromatin modification [BP], RNA metabolic process [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], chromosome [CC], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], nucleic acid binding [MF], embryonic skeletal system development [BP], chromatin organization [BP], skeletal system development [BP], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP], zeta DNA polymerase complex [CC], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_349_11	5	0.8	2.80E-04	SH3PXD2B, SNX3, PTCH1, CIZ1, GAS1	phosphatidylinositol-3-phosphate binding [MF], cyclin binding [MF], dorsal/ventral neural tube patterning [BP]
CG_adsipsc_promoter_n_RM_14_323_6	1	0.2	3.23E-04	RAB35, ARRDC3, RRAS	negative regulation of heat generation [BP], negative regulation of locomotion involved in locomotory behavior [BP], GDP binding [MF]
CG_adsipsc_promoter_n_RM_12_363_12	3	0.6	2.28E-04	PARD3, PCGF2, PCGF6, CYTH1	establishment of epithelial cell polarity [BP], PRC1 complex [CC]
CG_adsipsc_promoter_n_RM_12_424_16	4	0.8	2.26E-04	ABCG2, ABCC4	ATPase activity, coupled to transmembrane movement of substances [MF], 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [MF]
CG_adsipsc_promoter_n_RM_12_25_20	5	1.0	3.05E-04	SIK1, DVL1, STK17B, CAMK2B, ULK2	protein autophosphorylation [BP], collateral sprouting [BP]
CG_adsipsc_promoter_n_RM_14_321_2	1	0.2	3.00E-04	CXCL2, CXCL3	chemokine activity [MF]
CG_adsipsc_promoter_n_RM_12_15_9	3	0.4	2.32E-04	GJA3, CBLN2, GJB6, FOXA1, CBLN1, LAMA1	embryo development [BP], connexon complex [CC], positive regulation of synapse assembly [BP], epithelial tube branching involved in lung morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_370_8	3	0.4	2.29E-04	VDAC1, SSU72, ZC3H3	voltage-gated anion channel activity [MF], mRNA polyadenylation [BP]
CG_adsipsc_promoter_n_RM_12_377_12	5	0.8	2.28E-04	MBD2, MLH3	satellite DNA binding [MF]
CG_adsipsc_promoter_n_RM_14_35_13	3	0.4	3.99E-04	GATA2	ventral spinal cord interneuron differentiation [BP]
CG_adsipsc_promoter_n_RM_12_435_14	3	0.6	1.90E-04	FOXP1, ACVR1, IFT172, MEIS3, MCMBP, LEF1, NKX6-1, HMX1	patterning of blood vessels [BP], ventral spinal cord development [BP], sequence-specific DNA binding [MF], chromatin binding [MF], dorsal/ventral pattern formation [BP], regulation of striated muscle tissue development [BP], pattern specification process [BP]
CG_adsipsc_promoter_n_RM_14_73_9	5	0.4	3.65E-04	CDK5	negative regulation of synaptic plasticity [BP], acetylcholine receptor activator activity [MF]
CG_adsipsc_promoter_n_RM_12_452_9	2	0.4	4.29E-04	STC2, SLBP, SRSF9, TMEM66, THOC7	mRNA export from nucleus [BP], regulation of store-operated calcium entry [BP]
CG_adsipsc_promoter_n_RM_14_306_5	2	0.2	2.75E-04	LYL1, HOXB3	definitive hemopoiesis [BP]
CG_adsipsc_promoter_n_RM_14_33_6	7	1.0	3.37E-04	BMP4, HOXA5, STK3, SLC6A4, FOXA1	epithelial-mesenchymal cell signaling [BP], negative regulation of organ growth [BP], lung epithelial cell differentiation [BP], bronchus development [BP], trachea development [BP], epithelial tube branching involved in lung morphogenesis [BP], lung morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_130_16	4	0.6	2.05E-04	MYL2, CDK5, SETD7, IGF2	muscle cell fate specification [BP], p53 binding [MF], acetylcholine receptor activator activity [MF], receptor activator activity [MF]
CG_adsipsc_promoter_n_RM_14_70_6	2	0.2	3.39E-04	SLC35B2, GABBR1	3'-phosphoadenosine 5'-phosphosulfate transport [BP], 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF], G-protein coupled receptor dimeric complex [CC]
CG_adsipsc_promoter_n_RM_12_300_14	2	0.4	1.97E-04	BMP4, NKX2-2	positive regulation of DNA-dependent DNA replication [BP], type B pancreatic cell development [BP]
CG_adsipsc_promoter_n_RM_14_3_7	2	0.2	2.21E-04	FECH	detection of UV [BP], ferrochelatase activity [MF]
CG_adsipsc_promoter_n_RM_12_460_18	6	1.0	1.92E-04	FASN	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF]
CG_adsipsc_promoter_n_RM_18_5_16	4	0.4	4.73E-04	TWIST1, FGFR2, TCF15, STAT5B, PTCH1, LYST, NCOR1, ICMT, SFRP5	multicellular organism growth [BP], neural tube closure [BP], cranial suture morphogenesis [BP], morphogenesis of embryonic epithelium [BP], post-anal tail morphogenesis [BP], positive regulation of natural killer cell activation [BP], embryo development [BP], regulation of multicellular organism growth [BP], negative regulation of phosphatidylinositol 3-kinase cascade [BP]
CG_adsipsc_promoter_n_RM_14_265_7	2	0.2	3.04E-04	BAD, HDAC7, TBX3, CLU	atrioventricular bundle cell differentiation [BP], sinoatrial node cell development [BP], activating transcription factor binding [MF], release of cytochrome c from mitochondria [BP], cellular response to chromate [BP]
CG_adsipsc_promoter_n_RM_12_182_26	4	0.6	3.71E-04	MED22, MTOR, MED13L	RNA polymerase II transcription cofactor activity [MF], regulation of fatty acid beta-oxidation [BP]
CG_adsipsc_promoter_n_RM_12_121_19	4	0.6	3.22E-04	BCL11A, CERK, SMAD2, DLL1, MEF2D, DGKQ	activating transcription factor binding [MF], loop of Henle development [BP], negative regulation of collateral sprouting [BP], diacylglycerol kinase activity [MF]
CG_adsipsc_promoter_n_RM_14_120_8	3	0.2	1.81E-04	SNAP91, IP6K3, IP6K1, EEA1	inositol hexakisphosphate 3-kinase activity [MF], 1-phosphatidylinositol binding [MF], inositol hexakisphosphate 1-kinase activity [MF], inositol-1,4,5-trisphosphate 3-kinase activity [MF], inositol hexakisphosphate 5-kinase activity [MF]
CG_adsipsc_promoter_n_RM_14_304_7	3	0.2	2.22E-04	LAMA5, LAMB1	basal lamina [CC], laminin-1 complex [CC], laminin-10 complex [CC]
CG_adsipsc_promoter_n_RM_14_122_8	4	0.6	5.07E-04	GATA2, LHX3	pituitary gland development [BP], ventral spinal cord interneuron differentiation [BP]
CG_adsipsc_promoter_n_RM_12_304_10	4	0.6	3.46E-04	KHDRBS2, HNRNPH1	poly(U) RNA binding [MF]
CG_adsipsc_promoter_n_RM_12_139_15	3	0.4	2.67E-04	FLT3, ABCB10	vascular endothelial growth factor signaling pathway [BP], integral to mitochondrial membrane [CC]
CG_adsipsc_promoter_n_RM_14_391_6	4	0.6	4.44E-04	BAD	pore complex assembly [BP]
CG_adsipsc_promoter_n_RM_12_302_18	1	0.2	3.39E-04	AXIN1, SFRP5, SMAD7	regulation of catenin import into nucleus [BP], I-SMAD binding [MF], post-anal tail morphogenesis [BP]
CG_adsipsc_promoter_n_RM_18_6_2	1	0.2	4.95E-04	LHX3, LHX5, CRH	ferulate metabolic process [BP], corticotropin-releasing hormone activity [MF], spinal cord association neuron differentiation [BP]
CG_adsipsc_promoter_n_RM_12_282_9	2	0.4	2.88E-04	PELI1, U2AF1, PIEZO1, PCID2, ALYREF, EZH1, BAD, EZH2, CBX8, SNRPG, SLBP	positive regulation of B cell differentiation [BP], ESC/E(Z) complex [CC], PcG protein complex [CC], response to dsRNA [BP], termination of RNA polymerase II transcription [BP], positive regulation of cell-cell adhesion mediated by integrin [BP]
CG_adsipsc_promoter_n_RM_14_194_10	3	0.4	3.42E-04	WNT10B, NFIB	chondrocyte differentiation [BP]
CG_adsipsc_promoter_n_RM_12_219_15	5	1.0	2.65E-04	NFIB, ASPH, PLA2G6, GPLD1, MYO5A, NEUROD2	cellular response to calcium ion [BP], regulation of store-operated calcium channel activity [BP], chondrocyte differentiation [BP], regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP]
CG_adsipsc_promoter_n_RM_12_305_12	5	0.8	3.66E-04	HID1, CYTH1	regulation of ARF protein signal transduction [BP], extrinsic to Golgi membrane [CC]
CG_adsipsc_promoter_n_RM_14_281_4	2	0.2	2.81E-04	APBA3, ZNF682, VOPP1, EPB41L4A, JUP, SALL1, ZNF70, CHEK2, EPB41L3	cytoskeletal anchoring at plasma membrane [BP], extrinsic to membrane [CC], regulation of gene expression [BP], regulation of transcription, DNA-dependent [BP], positive regulation of Wnt receptor signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_331_7	2	0.4	2.38E-04	HRAS	mitotic cell cycle G1/S transition checkpoint [BP]
CG_adsipsc_promoter_n_RM_14_54_3	3	0.4	2.71E-04	AK8, CDK5, CDK6, EEA1	synaptic vesicle endocytosis [BP], gliogenesis [BP], synaptic vesicle to endosome fusion [BP], cell dedifferentiation [BP], cyclin-dependent protein kinase holoenzyme complex [CC], ventricular system development [BP], cyclin-dependent protein kinase activity [MF]
CG_adsipsc_promoter_n_RM_12_413_14	4	0.8	3.95E-04	EEF1A2, DVL2, ARFRP1, LSG1, SEPHS1, TUBB2B, RAB5C	cell migration in hindbrain [BP], GTPase activity [MF], GTP binding [MF]
CG_adsipsc_promoter_n_RM_12_26_4	2	0.4	9.69E-05	TLR9, CDCA3, MB21D1, UBC, MAPK9, UNKL	protein ubiquitination [BP], innate immune response [BP], positive regulation of chemokine production [BP], JNK cascade [BP], toll-like receptor signaling pathway [BP], activation of innate immune response [BP], positive regulation of nitric-oxide synthase biosynthetic process [BP]
CG_adsipsc_promoter_n_RM_14_247_6	1	0.2	2.72E-04	NR4A2	habenula development [BP]
CG_adsipsc_promoter_n_RM_12_78_14	8	1.0	3.08E-04	KLF12, UBE2N, SNUPN, SIX2, PAX5, ETS1, BCOR, NCOA2	negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of histone H3-K36 methylation [BP], histone ubiquitination [BP], snRNA import into nucleus [BP], positive regulation of transcription from RNA polymerase II promoter [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_14_58_7	6	0.6	2.00E-04	SOD2, FLNA	detection of oxygen [BP], early endosome to late endosome transport [BP]
CG_adsipsc_promoter_n_RM_14_96_5	3	0.6	2.45E-04	TOLLIP, RAD21, HLCS, WNT4, EZH1, TBX3, CLIP1, SATB2, FOXN3, GFI1, HDAC4	negative regulation of steroid biosynthetic process [BP], positive regulation of protein sumoylation [BP], negative regulation of transcription from RNA polymerase II promoter [BP], osteoblast development [BP], protein palmitoylation [BP], nuclear matrix [CC], negative regulation of transcription, DNA-dependent [BP], negative regulation of cell differentiation [BP], mitotic cell cycle [BP], negative regulation of gene expression [BP], branching involved in mammary gland duct morphogenesis [BP]
CG_adsipsc_promoter_n_RM_12_123_15	8	1.0	3.65E-04	AXIN2, HSPA5, BAG5, FZD8, SLC22A17, ERI3, RRP8, MTOR, IVNS1ABP, CEBPA	protein domain specific binding [MF], intracellular [CC], ubiquitin protein ligase binding [MF], integral to organelle membrane [CC], positive regulation of transcription from RNA polymerase III promoter [BP], transcription from RNA polymerase III promoter [BP], cellular response to glucose starvation [BP], embryo development [BP]
CG_adsipsc_promoter_n_RM_12_56_6	5	0.8	5.95E-04	BCOR	negative regulation of histone H3-K36 methylation [BP]
CG_adsipsc_promoter_n_RM_14_245_5	3	0.4	2.33E-04	NKX6-2	negative regulation of cell fate commitment [BP]
CG_adsipsc_promoter_n_RM_14_183_6	3	0.4	4.42E-04	OSBPL7, TP53INP1	autophagic vacuole [CC]
CG_adsipsc_promoter_n_RM_12_21_13	2	0.4	2.95E-04	FOXJ1	glomerular parietal epithelial cell development [BP], negative regulation of humoral immune response mediated by circulating immunoglobulin [BP], positive regulation of central B cell tolerance induction [BP], positive regulation of lung ciliated cell differentiation [BP], central tolerance induction [BP]
CG_adsipsc_promoter_n_RM_12_455_13	3	0.4	2.61E-04	RDX, MYH9	cleavage furrow [CC]
CG_adsipsc_promoter_n_RM_12_146_17	7	1.0	3.47E-04	ITGB5, ERCC1, GDF2	multicellular organismal development [BP], nucleotide-excision repair complex [CC], growth [BP]
CG_adsipsc_promoter_n_RM_14_38_5	7	1.0	3.87E-04	TLR9, RBP4, HEY1, BMP4	heart trabecula formation [BP], bronchus development [BP], trachea development [BP], maintenance of gastrointestinal epithelium [BP]
CG_adsipsc_promoter_n_RM_12_284_13	3	0.6	4.91E-04	LIN9, CDC25A, SLC17A7, CAMK2B, PSMD12, GRIN2A, DLG4	excitatory synapse [CC], regulation of synaptic plasticity [BP], synapse [CC], regulation of excitatory postsynaptic membrane potential [BP], dendritic spine morphogenesis [BP], ionotropic glutamate receptor complex [CC], regulation of long-term neuronal synaptic plasticity [BP], mitotic cell cycle [BP], synaptic vesicle [CC]
CG_adsipsc_promoter_n_RM_14_113_6	3	0.4	2.42E-04	CLCN7, TPT1, NOTCH2, GPLD1	response to pH [BP], stem cell maintenance [BP], transepithelial transport [BP]
CG_adsipsc_promoter_n_RM_12_288_9	2	0.4	4.73E-04	PRICKLE1, ZIC5, HECTD1	neural tube closure [BP]
CG_adsipsc_promoter_n_RM_14_298_5	1	0.2	4.00E-04	PCYT2, PNKP, PID1	negative regulation of mitochondrial DNA replication [BP], nucleotide phosphorylation [BP], ethanolamine-phosphate cytidylyltransferase activity [MF]
CG_adsipsc_promoter_n_RM_14_147_10	9	0.8	3.22E-04	HEYL, FOXH1, FZD5, SCRIB	negative regulation of androgen receptor signaling pathway [BP], apoptotic process involved in morphogenesis [BP], negative regulation of androgen receptor activity [BP]
CG_adsipsc_promoter_n_RM_14_187_4	4	0.4	3.66E-04	HS3ST1, HSPG2, RBBP7, CAMK2B, MKX, ITPK1	tendon sheath development [BP], inositol-1,3,4-trisphosphate 6-kinase activity [MF], Golgi lumen [CC], inhibitory G-protein coupled receptor phosphorylation [BP], inositol-1,3,4-trisphosphate 5-kinase activity [MF], inositol tetrakisphosphate 1-kinase activity [MF], cellular heat acclimation [BP]
CG_adsipsc_promoter_n_RM_16_8_11	5	0.2	2.05E-04	PPP1CC, AXIN1, SUMO3, TOMM34, BAD, AP3D1, GPAM	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [BP], mitochondrial outer membrane [CC], protein localization to organelle [BP]
CG_adsipsc_promoter_n_RM_14_314_2	2	0.2	2.84E-04	DUSP8, DUSP16	inactivation of MAPK activity [BP], MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], MAPK export from nucleus [BP], MAP kinase tyrosine/serine/threonine phosphatase activity [MF]
CG_adsipsc_promoter_n_RM_14_241_8	2	0.2	3.43E-04	TBX20, WNT7A, PSIP1, CARHSP1, PABPC1	Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells [BP], activating transcription factor binding [MF], RNA polymerase II transcription coactivator activity [MF], supercoiled DNA binding [MF], embryonic heart tube elongation [BP], regulation of mRNA stability [BP], negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP]
CG_adsipsc_promoter_n_RM_14_115_6	3	0.2	2.86E-04	STX2, ZBTB17, QDPR	ectoderm development [BP], NADH binding [MF], 6,7-dihydropteridine reductase activity [MF]
CG_adsipsc_promoter_n_RM_12_402_12	4	0.8	4.01E-04	TOP1MT, TOP3A, AXIN1, GSK3A	DNA topoisomerase type I activity [MF], DNA topological change [BP], beta-catenin destruction complex [CC]
CG_adsipsc_promoter_n_RM_14_200_3	2	0.2	3.65E-04	PKD1, CEBPA	lung epithelium development [BP], lung development [BP]
CG_adsipsc_promoter_n_RM_14_124_4	4	0.6	2.55E-04	SIK1, PHF21A, CTBP1, DICER1, MTERFD2, YWHAZ	viral genome replication [BP], negative regulation of transcription from RNA polymerase II promoter [BP], regulation of transcription by chromatin organization [BP], protein targeting to mitochondrion [BP]
CG_adsipsc_promoter_n_RM_12_117_10	5	0.8	2.61E-04	SYMPK, FKBP5, DLG4, CSPG5, EGR2, HES4, MYH9, BCL11A, TRAIP, SLC23A1, RUNX3, PAX6, GLI3, CLU, AIFM2, HSP90AA1, DLC1, CIDEC, WNT7B, GBX2	axonogenesis [BP], negative regulation of protein homooligomerization [BP], hindbrain development [BP], brain development [BP], induction of apoptosis [BP], chaperone-mediated protein folding [BP], axon guidance [BP], neuron differentiation [BP], forebrain regionalization [BP], protein refolding [BP], positive regulation of protein dephosphorylation [BP], forebrain dorsal/ventral pattern formation [BP], nervous system development [BP]
CG_adsipsc_promoter_n_RM_12_27_17	3	0.6	3.01E-04	BCL2, MCL1	BH3 domain binding [MF]
CG_adsipsc_promoter_n_RM_12_103_11	1	0.2	3.21E-04	DGKQ	cAMP-mediated signaling [BP]
CG_adsipsc_promoter_n_RM_12_252_8	3	0.6	1.01E-04	WNT11	negative regulation of fibroblast growth factor production [BP], positive regulation of transforming growth factor beta2 production [BP]
CG_adsipsc_promoter_n_RM_12_494_7	2	0.4	2.70E-04	ANKH	inorganic diphosphate transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_14_72_11	3	0.4	3.55E-04	BMP4, SCRIB, EN1, LEF1, PTCH1, EFNB2	trachea development [BP], negative regulation of striated muscle tissue development [BP], neural tube closure [BP], osteoblast differentiation [BP], limb morphogenesis [BP], sprouting angiogenesis [BP], embryonic limb morphogenesis [BP], neural tube patterning [BP], apoptotic process involved in morphogenesis [BP], dorsal/ventral neural tube patterning [BP], dorsal/ventral pattern formation [BP], regulation of striated muscle tissue development [BP], mammary gland development [BP], nervous system development [BP]
CG_adsipsc_promoter_n_RM_14_1_9	1	0.2	3.61E-04	KLF12, MLL2, WNT10B, GNB1, MLL3, EN1, GDNF, NKX2-5, BRD3, FOXP3	chromatin modification [BP], histone methyltransferase complex [CC], positive regulation of transcription from RNA polymerase II promoter [BP], cardiac muscle cell apoptotic process [BP], pattern specification process [BP], regulation of transcription from RNA polymerase II promoter [BP], midbrain-hindbrain boundary development [BP]
CG_adsipsc_promoter_n_RM_14_19_8	3	0.4	4.28E-04	PTK2, ITGB5, PANK4, PEAK1, SDC1, PANK1	coenzyme A biosynthetic process [BP], pantothenate kinase activity [MF], focal adhesion [CC]
CG_adsipsc_promoter_n_RM_20_1_18	1	0.2	4.17E-04	PTK2, NOVA2, ONECUT1, FBXO11, BCL11A, KCTD1, USP7, TAF11, CDYL2, SHROOM4, MAFA, ELF2, CDK2AP1, CEBPA, ZNF3, EOMES, DGKI, RANBP9, VEZF1, NUAK1, NEUROG2, HEY1, TOP2A, EDF1, ZBTB2, ASH1L, ZZZ3, RP9, DNASE1L1, MECP2, ZNF367, TCEA1, ARFGEF1, PAX3, KCNB1, EVX2, THOC7, BRD3, RPS6KA3, TBL1XR1, GSK3B, GRIN2C, PIP4K2B, LCORL, PRKD2, LMF1	protein glycosylation in Golgi [BP], DNA binding [MF], protein N-terminus binding [MF], positive regulation of transcription, DNA-dependent [BP], positive regulation of cell differentiation [BP], transcription factor binding [MF], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], positive regulation of transcription from RNA polymerase II promoter [BP], nucleic acid binding [MF], nucleus [CC], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_14_108_8	2	0.2	3.53E-04	NCOR2, FZD4	cerebellum vasculature morphogenesis [BP], regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_RM_12_155_17	6	1.0	2.99E-04	OVOL2, PDF	N-terminal protein amino acid modification [BP], negative regulation of cell proliferation [BP], peptide deformylase activity [MF]
CG_adsipsc_promoter_n_RM_18_2_2	4	0.4	4.57E-04	PTK2	negative regulation of axonogenesis [BP], netrin-activated signaling pathway [BP]
CG_adsipsc_promoter_n_RM_14_4_5	2	0.2	6.03E-04	FZD4, ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], cerebellum vasculature morphogenesis [BP], inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_adsipsc_promoter_n_RM_14_240_6	2	0.2	2.69E-04	RTN4R, BCL9L	regulation of cell morphogenesis [BP], regulation of axonogenesis [BP]
CG_adsipsc_promoter_n_RM_14_359_13	7	0.8	4.42E-04	ATL3	endoplasmic reticulum organization [BP]
CG_adsipsc_promoter_n_RM_12_72_15	4	0.6	3.31E-04	SHANK1, SLIT1, KIFC3, BCL11A	regulation of dendrite development [BP], positive regulation of dendritic spine development [BP], negative regulation of axon extension [BP], establishment of nucleus localization [BP], epithelial cell-cell adhesion [BP]
CG_adsipsc_promoter_n_RM_14_278_13	5	0.4	2.89E-04	PARD3, CDKN1C, ANKRD27, CDKN2A, RAPGEF3, KIF16B	guanyl-nucleotide exchange factor activity [MF], cyclin-dependent protein kinase inhibitor activity [MF], phosphatidylinositol-3-phosphate binding [MF]
CG_adsipsc_promoter_n_RM_12_132_20	5	0.8	3.25E-04	ZNF423, BMP4	positive regulation of BMP signaling pathway [BP]
CG_adsipsc_promoter_n_RM_12_64_12	2	0.4	2.41E-04	FLOT2, PCSK4	acrosomal membrane [CC]
CG_adsipsc_promoter_n_RM_14_178_11	3	0.2	2.46E-04	PTK2, PLXNA2, PLXND1	embryo development [BP], semaphorin-plexin signaling pathway [BP], synapse assembly [BP], semaphorin receptor activity [MF]
CG_adsipsc_promoter_n_RM_14_188_6	2	0.2	3.72E-04	GNB2L1, MAPK1, PUM2	regulation of translation [BP], perikaryon [CC]
CG_adsipsc_promoter_n_RM_14_206_8	1	0.2	3.02E-04	ABCB6, ABCF2	ATP-binding cassette (ABC) transporter complex [CC]
CG_adsipsc_promoter_n_RM_14_221_2	2	0.2	4.41E-04	NUDT18, LSM4	GDP catabolic process [BP], 8-oxo-dGDP phosphatase activity [MF], 8-oxo-GDP phosphatase activity [MF], U6 snRNP [CC], dADP catabolic process [BP], dGDP catabolic process [BP], 8-hydroxy-dADP phosphatase activity [MF]
CG_adsipsc_promoter_n_RM_12_498_8	7	1.0	2.82E-04	ENAH, SDC4, FERMT2	focal adhesion [CC]
CG_adsipsc_promoter_n_RM_14_128_9	3	0.2	2.25E-04	EPHA2, YPEL1	neuron differentiation [BP], negative regulation of protein kinase B signaling cascade [BP]
CG_adsipsc_promoter_n_RM_12_481_15	4	0.6	3.07E-04	WNT4, DAPK3	negative regulation of testosterone biosynthetic process [BP], positive regulation of cortisol biosynthetic process [BP], positive regulation of canonical Wnt receptor signaling pathway [BP], negative regulation of testicular blood vessel morphogenesis [BP], negative regulation of male gonad development [BP]
CG_adsipsc_promoter_n_RM_14_225_6	2	0.4	4.59E-04	EPHA1, RACGAP1	positive regulation of GTPase activity [BP], activation of Rho GTPase activity [BP]
CG_adsipsc_promoter_n_RM_12_473_26	3	0.4	2.94E-04	SDC3, CD34, GPC3, ABCA2, GALC, RAB14, ACP2	lysosome [CC], lysosomal lumen [CC]
CG_adsipsc_promoter_n_RM_12_136_26	8	1.0	3.53E-04	CHD5, ERBB4, HIRA, HOXA7, ELMSAN1, IRF2BP2	transcription, DNA-dependent [BP], regulation of transcription, DNA-dependent [BP], cardiac muscle tissue regeneration [BP]
CG_adsipsc_promoter_n_RM_12_165_21	7	1.0	2.87E-04	FZD5, NRAP, TBX3, AAK1, PKD2L1, FLNA, CDKN2A	anterior/posterior axis specification, embryo [BP], protein stabilization [BP], alpha-actinin binding [MF], muscle alpha-actinin binding [MF]
CG_adsipsc_promoter_n_RM_12_286_19	8	0.8	2.89E-04	CLSPN, TLE3, ERCC1, RABAC1, TAF12, PSMD10, STAT5B, TERF2, SBDS, NCL, RYBP, LIN54, CPSF1, TOP2A, MCM7	protein C-terminus binding [MF], replicative cell aging [BP], negative regulation of telomere maintenance [BP], nucleoplasm [CC]
CG_adsipsc_promoter_n_RM_14_190_12	3	0.2	2.52E-04	LUZP1, DAP	ventricular septum development [BP], cellular response to amino acid starvation [BP], neural fold bending [BP]
CG_adsipsc_promoter_n_RM_14_294_6	2	0.2	3.44E-04	RUNX3, SOX18	nuclear chromatin [CC]
CG_adsipsc_promoter_n_RM_14_394_2	3	0.4	3.39E-04	ABCB6, CPT1A	heme-transporting ATPase activity [MF], integral to mitochondrial outer membrane [CC]
CG_adsipsc_promoter_n_RM_12_152_16	3	0.6	2.86E-04	HRAS, ULK3	cellular senescence [BP]
CG_adsipsc_promoter_n_RM_14_16_5	1	0.2	2.67E-04	MESP1	lateral mesoderm development [BP]
CG_adsipsc_promoter_n_RM_18_8_4	1	0.2	3.50E-04	TBX3	atrioventricular bundle cell differentiation [BP], sinoatrial node cell development [BP]
CG_adsipsc_promoter_n_RM_12_312_7	5	1.0	2.91E-04	SLC5A6, GANAB	biotin transport [BP], glucosidase II complex [CC], pantothenate transmembrane transport [BP]
CG_adsipsc_promoter_n_RM_12_411_12	4	0.8	3.00E-04	DLL1, COL4A3BP, T, NKX2-5, GNB1	positive regulation of heart contraction [BP], lipid homeostasis [BP], heart morphogenesis [BP], determination of heart left/right asymmetry [BP], cardiac muscle cell apoptotic process [BP], determination of left/right symmetry [BP]
CG_adsipsc_promoter_n_RM_14_392_3	2	0.4	2.84E-04	HPS4	positive regulation of eye pigmentation [BP]
CG_adsipsc_promoter_n_RM_12_209_9	6	1.0	2.65E-04	NFKBIA, FOXJ3, TLE1, MYH9, EZR, MED13, KCTD1	RNA polymerase II transcription cofactor activity [MF], uropod [CC], transcription factor binding [MF]
CG_adsipsc_promoter_n_RM_12_400_13	4	0.8	3.10E-04	BRD7, PTCH1, E2F7	negative regulation of G1/S transition of mitotic cell cycle [BP], negative regulation of cell division [BP]
CG_adsipsc_promoter_n_RM_14_227_3	2	0.2	4.34E-04	GART, FASTK	phosphoribosylformylglycinamidine cyclo-ligase activity [MF], phosphoribosylglycinamide formyltransferase activity [MF], phosphoribosylamine-glycine ligase activity [MF], Fas-activated serine/threonine kinase activity [MF]
CG_adsipsc_promoter_n_RM_12_193_8	3	0.4	2.22E-04	JAG2, HCN4, AMOT, TWIST1	in utero embryonic development [BP]
CG_adsipsc_promoter_n_RM_14_173_4	3	0.2	4.69E-04	TOP2A, ADRA1D, ALKBH8, NOTCH1, JAG2	response to DNA damage stimulus [BP], negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [BP], Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP], positive regulation of retroviral genome replication [BP], auditory receptor cell fate commitment [BP], Notch receptor processing [BP], DNA topoisomerase complex (ATP-hydrolyzing) [CC], regulation of extracellular matrix assembly [BP], viral integration complex [CC], venous endothelial cell differentiation [BP]
CG_adsipsc_promoter_n_RM_14_273_6	1	0.2	1.42E-04	CHST1	keratan sulfotransferase activity [MF]
CG_adsipsc_promoter_n_RM_20_12_2	1	0.2	1.27E-04	ZNF506, ZNF43, ZNF737, ZNF91, ZNF117	DNA binding [MF], zinc ion binding [MF]
CG_adsipsc_promoter_n_RM_12_231_9	3	0.6	1.87E-04	FGD6, BVES	regulation of Cdc42 GTPase activity [BP]
CG_adsipsc_promoter_n_RM_14_63_16	10	0.8	3.51E-04	KIF17, EIF5A2, AKTIP	protein transport [BP]
CG_adsipsc_promoter_n_RM_12_408_13	5	1.0	2.64E-04	PANK4, PANK1	coenzyme A biosynthetic process [BP], pantothenate kinase activity [MF]
CG_adsipsc_promoter_n_RM_14_119_4	2	0.2	2.58E-04	POLD4, RFC4	nucleotide-excision repair, DNA gap filling [BP], telomere maintenance via recombination [BP], telomere maintenance via semi-conservative replication [BP]
CG_adsipsc_promoter_n_RM_14_292_5	2	0.2	1.76E-04	DNPH1, MAFB, FBXO27, FBXO2, VCP	nucleoside deoxyribosyltransferase activity [MF], deoxyribonucleoside 5'-monophosphate N-glycosidase activity [MF], rhombomere 6 development [BP], ER-associated protein catabolic process [BP], SCF ubiquitin ligase complex [CC]
CG_adsipsc_promoter_n_RM_12_319_14	7	1.0	2.74E-04	HMGB1, FZD5, SMAD2, SCRIB	lung development [BP], apoptotic process involved in morphogenesis [BP], establishment of apical/basal cell polarity [BP]
CG_adsipsc_promoter_n_RM_14_396_6	3	0.4	4.81E-04	SMARCC1, ACTL6B, UGDH	UDP-glucose 6-dehydrogenase activity [MF], nBAF complex [CC], SWI/SNF complex [CC]
CG_adsipsc_promoter_n_RM_14_8_8	3	0.4	3.28E-04	AES, SMAD7, TBX3	organ morphogenesis [BP], male genitalia development [BP], ventricular septum morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_208_3	3	0.2	3.52E-04	HCN4, PDE10A	cAMP binding [MF]
CG_adsipsc_promoter_n_RM_12_52_13	4	0.6	3.97E-04	RNASET2	ribonuclease T2 activity [MF]
CG_adsipsc_promoter_n_RM_16_20_2	2	0.2	3.43E-04	KCNJ11, PTGR1, DIAPH1, PABPC1	2-alkenal reductase [NAD(P)] activity [MF], ion channel binding [MF], negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP]
CG_adsipsc_promoter_n_RM_14_114_11	9	0.8	1.95E-04	RHOA, HDAC4, CELSR1, PKM, ARHGAP4	Rho protein signal transduction [BP], potassium ion binding [MF]
CG_adsipsc_promoter_n_RM_12_14_6	3	0.4	2.80E-04	NEUROG1, ADCY8, NTF4	cell fate commitment [BP], long-term memory [BP]
CG_adsipsc_promoter_n_RM_12_224_19	3	0.6	3.15E-04	ELOVL4, ELOVL2, PRSS8, AKT1	positive regulation of sodium ion transport [BP], long-chain fatty-acyl-CoA biosynthetic process [BP], very long-chain fatty acid biosynthetic process [BP]
CG_adsipsc_promoter_n_RM_20_16_3	2	0.2	3.50E-04	CDK6, PTCH1	cyclin binding [MF], negative regulation of osteoblast differentiation [BP]
CG_adsipsc_promoter_n_RM_12_356_12	4	0.6	2.57E-04	ABCG2, SLC38A2, SLC17A7, SLC2A13, ABCA3, RAB11FIP2	transmembrane transport [BP]
CG_adsipsc_promoter_n_RM_14_367_12	3	0.4	2.73E-04	E2F8, AXIN2, YBX2, SRD5A2	sterol 5-alpha reductase activity [MF], mRNA stabilization [BP], cell cycle comprising mitosis without cytokinesis [BP], translational attenuation [BP], regulation of chondrocyte development [BP]
CG_adsipsc_promoter_n_RM_14_52_9	2	0.2	2.20E-04	NOP14	Noc4p-Nop14p complex [CC]
CG_adsipsc_promoter_n_RM_14_339_10	2	0.2	3.03E-04	GNB1, MLL3, STRA13, WDR82, FANCC, PROM1	Fanconi anaemia nuclear complex [CC], histone methyltransferase activity (H3-K4 specific) [MF], photoreceptor outer segment membrane [CC], removal of superoxide radicals [BP]
CG_adsipsc_promoter_n_RM_12_20_10	5	1.0	2.18E-04	FGFR1	chordate embryonic development [BP]
CG_adsipsc_promoter_n_RM_12_298_15	5	1.0	1.99E-04	OPLAH, TTLL1	5-oxoprolinase (ATP-hydrolyzing) activity [MF], tubulin-glutamic acid ligase activity [MF]
CG_adsipsc_promoter_n_RM_12_426_15	6	1.0	3.48E-04	TGDS	nucleotide-sugar metabolic process [BP]
CG_adsipsc_promoter_n_RM_14_255_17	1	0.2	2.74E-04	POU4F1	proprioception involved in equilibrioception [BP]
CG_adsipsc_promoter_n_RM_14_352_8	1	0.2	2.42E-04	NR3C1, SLC30A1, ASTL	glutamic-type peptidase activity [MF], glucocorticoid receptor activity [MF], cortical granule [CC], negative regulation of zinc ion transmembrane import [BP]
CG_adsipsc_promoter_n_RM_12_214_10	4	0.8	2.06E-04	SMAD2, AGO2, MNX1	post-embryonic development [BP]
CG_adsipsc_promoter_n_RM_12_279_6	4	0.6	3.85E-04	MECP2	neurological system process involved in regulation of systemic arterial blood pressure [BP]
CG_adsipsc_promoter_n_RM_14_10_12	2	0.2	3.69E-04	PCID2, TCF3, STAT5B	Peyer's patch development [BP], positive regulation of B cell differentiation [BP], B cell differentiation [BP], natural killer cell differentiation [BP]
CG_adsipsc_promoter_n_RM_12_394_7	5	1.0	3.00E-04	NKX3-1	branching morphogenesis of an epithelial tube [BP]
CG_adsipsc_promoter_n_RM_12_421_20	5	1.0	4.47E-04	SAV1, FGF10	lung epithelium development [BP], lung epithelial cell differentiation [BP]
CG_adsipsc_promoter_n_RM_12_334_4	5	1.0	2.89E-04	ATP6V1H	vacuolar proton-transporting V-type ATPase, V1 domain [CC]
CG_adsipsc_promoter_n_RM_14_69_12	6	0.6	4.27E-04	STRA13, C1orf86	Fanconi anaemia nuclear complex [CC]
CG_adsipsc_promoter_n_RM_14_228_10	2	0.2	2.71E-04	MYO5B, HYAL2, DPYS	water transport [BP], receptor signaling protein tyrosine kinase inhibitor activity [MF], thymine binding [MF], uracil binding [MF]
CG_adsipsc_promoter_n_RM_14_2_3	1	0.2	2.41E-04	MYO1E, ABO, RBBP7, MKX, MYH10	tendon sheath development [BP], fucosylgalactoside 3-alpha-galactosyltransferase activity [MF], microfilament motor activity [MF], glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [MF], actin filament-based movement [BP], cellular heat acclimation [BP], actin filament binding [MF]
CG_adsipsc_promoter_n_RM_12_44_13	3	0.4	3.28E-04	ATAD2B, BAZ1B, WNT3	midbrain-hindbrain boundary development [BP], histone acetyl-lysine binding [MF]
CG_adsipsc_promoter_n_RM_12_113_5	6	1.0	3.62E-04	CBX4, MEIS3, CREB3L2, POU4F1, MTSS1, SALL1, HOXA1, TLR9, GATA2, BIN3, IKZF2, PDGFB	semicircular canal development [BP], enhancer sequence-specific DNA binding [MF], anatomical structure morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], transcription regulatory region DNA binding [MF], outer ear morphogenesis [BP], cytoskeletal adaptor activity [MF], kidney epithelium development [BP], positive regulation of transcription from RNA polymerase II promoter [BP], chromatin binding [MF], urogenital system development [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF], central nervous system neuron differentiation [BP], RNA polymerase II distal enhancer sequence-specific DNA binding [MF], regulation of neural precursor cell proliferation [BP]
CG_adsipsc_promoter_n_RM_12_41_10	6	0.8	3.17E-04	KLHL21, SYT15, TUBGCP3	polar microtubule [CC], extrinsic to membrane [CC]
CG_adsipsc_promoter_n_RM_12_390_4	2	0.2	3.08E-04	CHSY1, OAT, BCL11B, SMURF1	negative regulation of ossification [BP], striatal medium spiny neuron differentiation [BP], ornithine-oxo-acid transaminase activity [MF], olfactory bulb axon guidance [BP]
CG_adsipsc_promoter_n_RM_12_213_14	8	1.0	3.11E-04	UROC1, JHDM1D, CKB, FGFR2, MED24, ALX4, ERCC1, STAT5B, SH2D2A, FTCD, OVOL2, RAB3A, ADA, NKX2-2, FGF3, PAX8, IRX3, IRX2, WNT7A	histidine catabolic process to glutamate and formamide [BP], response to interleukin-15 [BP], digestive tract development [BP], anatomical structure morphogenesis [BP], histidine catabolic process to glutamate and formate [BP], post-embryonic development [BP], histidine catabolic process [BP], positive regulation of transcription, DNA-dependent [BP], embryonic digestive tract development [BP], morphogenesis of embryonic epithelium [BP], Peyer's patch development [BP], embryonic organ development [BP], dorsal/ventral pattern formation [BP], otic vesicle development [BP], specification of loop of Henle identity [BP], cell differentiation [BP], creatine metabolic process [BP]
CG_adsipsc_promoter_n_RM_12_336_5	4	0.6	5.08E-04	TRAF1, IRF2, CAMK1, IL15RA, TONSL, BAZ1A, ECH1, ARID4B, TMEM30B, DEDD2, RELA, GEM, SERTAD1	protein binding [MF]
CG_adsipsc_promoter_n_RM_14_151_2	1	0.2	3.08E-04	MKL1, WNT4, NACC2	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of testosterone biosynthetic process [BP], negative regulation of testicular blood vessel morphogenesis [BP], smooth muscle cell differentiation [BP], positive regulation of cortisol biosynthetic process [BP], negative regulation of male gonad development [BP]
CG_adsipsc_promoter_n_RM_12_55_17	4	0.8	2.90E-04	DENND1A, RAB3A, NDN, PLAGL2	respiratory system process [BP], synaptic vesicle endocytosis [BP], post-embryonic development [BP]
CG_adsipsc_promoter_n_RM_12_418_16	3	0.6	3.17E-04	MYL3, IRF7	regulation of MyD88-dependent toll-like receptor signaling pathway [BP], establishment of viral latency [BP], regulation of MyD88-independent toll-like receptor signaling pathway [BP], negative regulation of macrophage apoptotic process [BP], myosin II heavy chain binding [MF]
CG_adsipsc_promoter_n_RM_14_121_9	7	1.0	3.89E-04	LDB1, BRMS1, ATXN1, DEDD2	negative regulation of transcription, DNA-dependent [BP]
CG_adsipsc_promoter_n_RM_12_495_16	6	1.0	2.46E-04	PLXNB1, PPAP2C, DUSP6, SOX7, DUSP26, FGFR1, TGFB1	protein dephosphorylation [BP], regulation of heart growth [BP], salivary gland morphogenesis [BP], phosphoprotein phosphatase activity [MF], extracellular matrix assembly [BP], cell migration [BP], endoderm development [BP], protein tyrosine phosphatase activity [MF], endoderm formation [BP]
CG_adsipsc_promoter_n_RM_14_333_16	6	0.8	3.64E-04	NOP14, SLC35B2	Noc4p-Nop14p complex [CC], 3'-phosphoadenosine 5'-phosphosulfate transport [BP], 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_RM_14_320_3	2	0.4	2.29E-04	GAMT, SEPT12, NR3C1	guanidinoacetate N-methyltransferase activity [MF], glucocorticoid receptor activity [MF], sperm annulus [CC], mammary gland duct morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_81_5	10	0.8	4.31E-04	GAMT	organ morphogenesis [BP]
CG_adsipsc_promoter_n_RM_14_139_16	10	1.0	2.00E-04	SLC6A16	neurotransmitter:sodium symporter activity [MF], neurotransmitter transporter activity [MF]
CG_adsipsc_promoter_n_RM_12_133_20	4	0.6	1.42E-04	ARHGEF2, TUBGCP6, CDK6, JAKMIP1	microtubule binding [MF], ruffle [CC]
CG_adsipsc_promoter_n_RM_12_98_10	4	0.8	2.33E-04	NIN, PLCD3, SOCS3, HS6ST1, IFT20	centrosome localization [BP], placenta blood vessel development [BP], labyrinthine layer blood vessel development [BP]
CG_adsipsc_promoter_n_RM_12_247_12	6	1.0	1.82E-04	NUP160, RAB3A, NUP98, EGR3	nuclear pore outer ring [CC], neuromuscular synaptic transmission [BP]
CG_adsipsc_promoter_n_RM_12_368_13	2	0.2	1.51E-04	CPSF1, HNRNPF	regulation of RNA splicing [BP], RNA splicing [BP]
CG_adsipsc_promoter_n_RM_16_18_2	2	0.2	2.08E-04	TOP2B, SMAD9, SAMHD1	metal ion binding [MF]
CG_adsipsc_promoter_n_RM_12_342_18	6	1.0	3.25E-04	PLXNB1, IRS2, STAT5B, PPP1R9B, FGFR1, PDGFB	phosphatidylinositol-mediated signaling [BP], positive regulation of phosphatidylinositol 3-kinase cascade [BP], valine metabolic process [BP], cell migration [BP]
CG_adsipsc_promoter_n_RM_14_275_6	3	0.2	3.66E-04	GNB1, SFRP1	cellular response to prostaglandin E stimulus [BP]
CG_adsipsc_promoter_n_RM_12_330_9	2	0.2	4.21E-04	SGK223, BAZ1B	vitamin D receptor activator activity [MF], DNA replication-dependent nucleosome disassembly [BP], non-membrane spanning protein tyrosine kinase activity [MF]
CG_adsipsc_promoter_n_RM_18_7_2	1	0.2	9.09E-05	BRF1, CITED1	response to interleukin-9 [BP], transcription factor TFIIIB complex [CC], response to interleukin-11 [BP]
CG_adsipsc_promoter_n_RM_12_442_10	4	0.8	3.07E-04	SMAD7, SMAD2, TAF12, ZNF18, PITX2, BCL9L, COL2A1, CNR1, CEBPA, MAML3, KLF14, GATM, MAPK1, PCLO, LIPA, NFKBIA, PDLIM1, SNUPN, ZNF827, GMEB2, RTTN, ZNF503, BRD3, SOX21, TRPS1, MAX, RFX3, FOXA2, CDK5, CDK6, HES2, ZNF467, ZCCHC11	pancreas development [BP], transcription factor complex [CC], transcription coactivator activity [MF], insulin secretion [BP], regulation of transcription, DNA-dependent [BP], sensory perception of pain [BP], nucleic acid binding [MF], I-SMAD binding [MF], transcription factor binding [MF], type I transforming growth factor beta receptor binding [MF], lung development [BP], negative regulation of cell differentiation [BP], response to nutrient [BP], synaptic vesicle exocytosis [BP], lipopolysaccharide-mediated signaling pathway [BP], positive regulation of transcription from RNA polymerase III promoter [BP], determination of left/right symmetry [BP], transcription, DNA-dependent [BP], regulation of gene expression [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP]